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Innate immunity and Toll-like receptors (TLRs) 
Innate immunity is the first line of defense against infection and injury, and it plays a 
crucial role in maintaining homeostasis and preventing pathogen invasion of host 
tissues (1, 2). It eliminates a great variety of microbial invaders and is essential for the 
activation of the adaptive immune response (1, 2). Innate immunity consists of many 
components, such as humoral components including proteins from the pentraxin 
family and the complement system. It also includes specialized cell types such as 
macrophages, neutrophils, dendritic cells and natural killer cells. In addition, epithelial 
cells also contribute to innate immunity as physical barriers and producers of 
antimicrobial proteins (2). The communication between the various cell types involved 
in innate and adaptive immunity is orchestrated by signaling peptides, including 
cytokines and chemokines, as well as lipid mediators. 
Recognition of pathogens and other danger signals by host innate immunity is 
mostly based on the specific interaction between pathogen- and damage-associated 
molecular patterns (PAMPs and DAMPs) and germline-encoded pattern recognition 
receptors (PRRs) (3, 4). Among the most important PRRs are the Toll-like receptors 
(TLRs). TLRs are type I transmembrane glycoproteins, consisting of an ectodomain 
that contains ligand-binding motifs (leucine-rich repeats and cysteine-rich repeats), a 
transmembrane domain and a cytoplasmic signaling domain (Toll/IL-1 receptor (TIR) 
homology domain) (5). There are 10 TLRs in humans and an additional 3 in rodents. 
Generally, TLR1, 2, 4, 5, 6 and 10 are localized in the cytoplasmic membrane, and TLR3, 
7, 8 and 9 are localized in the endosomal membrane. However, their cellular 
distribution varies in some tissues; for instance, TLR2 and TLR4 are also found 
intracellularly localized in human corneal epithelial cells (6), and TLR3, 7 and 9 are 
found on the cell surface of airway epithelial cells as well (7) (Fig. 1). It has been 
hypothesized that each TLR has a distinct function in terms of PAMP and DAMP 
recognition (5, 8).  
TLRs recognize distinct PAMPs by forming hetero- or homo-dimers. Examples of 
heterodimer recognition are TLR2/TLR1 and TLR2/TLR6 that recognize tri- (9, 10) or 
di-acylated (11, 12) lipoprotein. TLR2 as a heterodimer also recognizes gram positive 
bacteria, mycobacteria and their cell wall components, such as glycolipids (13, 14) and 
glycoprotein (15, 16) to trigger the production of cytokines and chemokines. Typical 
synthetic ligands that are recognized by TLR2 heterodimers are Pam3CSK4 and 
Pam2CSK4. These synthetic lipopeptides can mimic the acylated amino terminus of 
bacterial lipoproteins, and are often used to trigger TLR2 activation in experimental 
settings. TLR10 has recently been shown to act as a heterodimer with TLR2 to sense 
microbes and fungi (17, 18). However hetero-dimerization of TLR10 with TLR2, does 
not lead to the activation of typical TLR-induced signaling, including NF-κB-, IL-8-, or 





different pathways than those used by TLR1 and TLR6 heterodimers (17, 18). This is 
suggested by the observation that TLR10, alone or in cooperation with TLR2, fails to 
activate typical TLR-induced signaling, including NF-κB-, IL-8-, or IFN-β-driven 
reporters (17) and that TLR10 is not involved in recognition of known TLR2 ligands (18). 
TLR10 has also been suggested to induce anti-inflammatory responses by hetero-
dimerizing with TLR2 (6). One possible mechanism for a TLR10 anti-inflammatory 
function is as an inhibitory receptor when forming heterodimers with TLR2; the other 
one is that TLR10 mediates the specific induction of an anti-inflammatory cytokine IL-1 
receptor antagonist (IL-1Ra), which is known as IL-1 inhibitor (6). TLR10 was also 
shown to dimerize with TLR1 in a co-immunoprecipitation study in human cells (19). 
TLR6 can also dimerize with TLR4 in response to endogenous ligands, promoting 
sterile inflammation (20). There are the following examples of TLR homodimer 
recognition: TLR4 recognizes bacterial lipopolysaccharide (LPS); TLR5 recognizes 
bacterial flagellin (21); TLR3 recognizes viral double strand RNA (dsRNA) and synthetic 
analogs of dsRNA, such as Poly I:C (22); TLR7 and 8 recognize viral single-strand RNA, 
miRNA and several anti-viral compounds (23, 24) and TLR9 recognizes unmethylated 
CpG DNA of bacterial and viral origin (25).  
Besides dimerization between each other, TLRs also need other accessory molecules 
or PRRs to recognize microbes and ligands. For instance, TLR4 needs the assistance 
from LPS binding protein (LBP), CD14 protein and the MD2 protein for recognition of 
LPS from various gram negative bacteria (26). TLR2 recognizes lipoteichoic acids (LTA), 
peptidoglycan (PGN), and lipopeptides (LP) and other membrane constituents from 
gram positive and negative bacteria and mycobacteria. Recognition of this diverse 
group of compounds needs the cooperation of TLR2 with other proteins (27). CD14 is 
reported to enhance TLR2/1 surface recognition of tri-acylated but not di-acylated 
lipopeptides (28), and significantly enhances TLR2 activation by facilitating 
lipopeptide binding and TLR2 hetero-dimerization (29). Scavenger receptors are also 
linked to TLR2 function (30); for instance, CD36 is a selective and non-redundant 
sensor of microbial di-acylglycerides that signals via the TLR2/6 heterodimer (31). In 
addition to these co-receptors, integrin β3 (32), Dectin-1 (33) and CXCR4 (34) are also 
reported to function as co-receptors for TLR2, and assist to modify the recognition of 
pathogens and the subsequent signal transduction. We believe that more co-receptors 
of TLRs will be found, and that a better understanding of the interaction between TLRs 
and their co-receptors is necessary. This will help us to understand the similarities and 
differences of intracellular signaling induced by different TLRs and to elucidate the 
mechanism of pathogen-defense by the host innate immune system. 
TLR signaling pathways 
After TLR activation, the intracellular signaling starts with the recruitment of adaptor 





(Myd88) (35), MyD88 adaptor-like (Mal) (also called TIR domain-containing adaptor 
protein, Tirap) (36, 37), TIR domain-containing adaptor protein inducing interferon-β 
(TRIF) (38), TIR-containing adaptor molecule (TICAM) (39), and TRIF-related adaptor 
molecule (TRAM) (40). With the exception of TLR3, Myd88 functions as a recruitment 
factor for all TLRs. For TLR2 and TLR4 the additional adaptor Mal is needed as well. 
For TLR3, the recruited adapter is TRIF, which can also cooperate with TRAM to 
recruit for TLR4 (Fig.1). After recruitment of TIR-domain containing adaptors, IL-1R-
associated protein kinases (IRAKs) (1, 2 and 4) are activated (41), followed by activation 
of tumor necrosis factor receptor-associated factor 6 (TRAF6) (42). Through TRIF, the 
kinase receptor interacting protein 1 (RIP1) is activated (43). Subsequently, TRAF6 and 
RIP1 activate a complex of TGF-β-activated kinase 1 (TAK1)/ TAK1-binding proteins 
(TAB1, 2 and 3), which in turn activates an IκB kinase (IKK) complex (IKK1, 2 and IKK-γ, 
also named NEMO) and the mitogen-activated protein kinases (MAPK) family, 
including extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinases (JNKs) 
and p38 MAPKs. Lastly, activator protein 1 (AP-1) and NF-ᴋB are activated (Fig.1), 
inducing cell survival, proliferation, activation, and production of chemokines and 
cytokines. In addition to activation of AP-1 and NF- ᴋB, TLR9 can signal through 
MyD88 to trigger TRAF6/IRAK4/TRAF3-dependent activation of IRF7 to induce type-I 
interferon (IFN) expression (44) (Fig.1). TLR3 and 4 can trigger Myd88-independent 
signaling through TRIF and TRAF3, inducing non-canonical IKKs, TANK-binding 
kinase 1 (TBK1), and IKKε pathways, and finally, they activate the transcription factor 
IRF3 and induce type-I IFN (IFN-β) and IL-10 production (45) (Fig.1).  
Negative feedback regulation of TLR signaling 
The activation of TLR signaling and the production of cytokines, chemokines and type-
I IFN are crucial for host defensive responses against pathogens (15, 46, 47). However, 
the aberrant and excessive activation of TLRs may contribute to auto-immune diseases 
and chronic inflammatory responses and even to an increase in infections (48-51). To 
avoid these excessive responses, the host needs to negatively regulate TLR activation. 
Such negative regulation mechanisms include dissociation of adaptor complexes, 
degradation of signal proteins and transcriptional regulation (52). In terms of 
dissociation of adaptor complexes, TRAM adaptor with GOLD domain (TAG) and 
sterile alpha- and TIR motif-containing protein (SARM), were reported to inhibit the 
TRIF-dependent pathway (53, 54). The Toll-interacting protein (TOLLIP), first 
discovered as a regulator of the IL-1R pathway (55) inhibits IRAK phosphorylation. 
TOLLIP also directly associates with TLR2 and suppresses the phosphor-rylation and 
kinase activity of IRAK1 and thereby facilitates termination of TLR2 signaling (56). 
TRAF family member-associated NF-κB activator (TANK), TNFα-induced protein 3 
(TNFAIP3, known as A20), suppressor of cytokine signaling 3 (SOCS3) and the small 
heterodimer partner (SHP, also called NR0B2) can inhibit TRAF6 ubiquitination (57-






FIGURE 1 TLR signaling in mammals. The cellular distribution of TLRs can be variable. In some cases, 
TLR2 and TLR4 are found in endosomal membranes and TLR3, TLR7 and TLR9 are found on the cell 
surface. TLR signaling is activated by the recognition of ligands and microbes and is modulated by 
several negative regulators. The inhibitors or the negative regulators of the TLR signaling are 
indicated in red color. Figure adapted from McClure and Massari (61). 
 
κB-dependent responses by interacting with IKKα and IKKβ and thereby blocks their 
phosphorylation (62). A20 also blocks IKKs activation through stimulation of 
polyubiquitin binding to NEMO (IKKγ) (63). NLR family member X1 (NLRX1) 
negatively regulates TLR-induced NF-κB signaling by targeting both TRAF6 and IKK 
complex (64) (Fig.1). 
With regard to degradation of signaling proteins, SOCS proteins promote 
deterioration of TIRAP (MAL) or TRAF proteins (65). Moreover, the integrin CD11b is 
activated by TLR-triggered phosphatidylinositol 3-OH kinase (PI(3)K) and the effector 
L-lysine cyclodeaminase (RapL) and feeds back to inhibit TLR signaling by activating 
the tyrosine kinases Src and Syk. Syk interacts with and induces tyrosine 
phosphorylation of MyD88 and TRIF, which leads to degradation of these adaptor 
molecules by the E3 ubiquitin ligase Cbl-b (66) (Fig.1). Pellino-3, a member of the E3 
ubiquitin ligases family, was also reported to act as a negative regulator of TLR2 and 





involve PDZ and LIM domain protein 2 (PDLIM2) (68), tripartite-motif containing 
proteins (TRIM) (69, 70) and peptidyl-prolyl isomerase (Pin1) (71).  
For transcriptional regulation, Cyclic AMP-dependent transcription factor (ATF3) 
(72), B-cell CLL/lymphoma 3 (Bcl-3) (73), nuclear receptor related 1 protein (Nurr1) (74) 
and transcription factor aryl hydrocarbon (Ah) receptor (75) are involved in the 
negative regulation of TLR signaling (Fig.1). Interestingly, the Ah receptor has recently 
been shown to function also as a PRR (76). 
Negative regulation of ligand recognition by TLRs 
In short, the positive and negative regulation of TLR signaling depends on the 
cooperation between TLRs and other accessory molecules or PRRs to form functional 
multi-receptor clusters, and also on the interaction between the multi-receptor 
clusters of TLRs and the microbial and endogenous ligands. For instance, through 
elucidating the crystal structures of staphylococcal superantigen-like protein 3 (SSL3) 
and its complex with TLR2, Koymans et al. (77) showed that SSL3 interferes with TLR2 
activation with both ligand binding and receptor dimerization to prevent the 
downstream signaling (77). In addition, Yoo et al (78) demonstrated that 
crystal structures of TLR8 in complex with two most active compounds confirmed 
important binding interactions that play a key role in ligand occupancy and biological 
activity. These studies suggest that structure-specific binding processes are the 
foundation of the recognition by TLRs of different microbes and PRRs. On the other 
hand, some additional upstream factors are also involved in the interactions between 
TLRs and various ligands or microbes. In Drosophila, Toll and other TLRs are not 
directly involved in ligand recognition, but the extracellular factor Spaetzle (or Spätzle 
[Spz]) initiates protease cascades leading to the activation of TLR signaling (79, 80). In 
a recent, study Hepburn et al. (81) identified a functional equivalent of Spaetzle in 
vertebrates, a neurotrophin named nerve growth factor β (NFG-β) which is structurally 
related to cystine-knot proteins. It was shown to be released by macrophages in 
response to Staphylococcus aureus infection. The activation of the high-affinity 
receptor of NFG-β, tropomyosin-related kinase receptor A (TRKA), enhances the 
intracellular killing of S. aureus. These NFG-β-TRKA signaling-dependent responses 
are also dependent on TLR signaling, suggesting an evolutionarily conserved 
interaction between cysteine knot proteins and Toll family receptors (81). 
TLR function in Mycobacterium tuberculosis infection 
Mycobacterium tuberculosis (Mtb) is an intracellular pathogen and the causative agent 
of tuberculosis (TB), It causes ill-health among millions of people each year and ranks 
alongside the human immunodeficiency virus (HIV) as a leading cause of death 
worldwide and kills about 1.5 million people annually (82). TB can be distinguished as 





cough with sputum and blood at times, chest pains, weakness, weight loss, fever and 
night sweats (83). Latent TB does not show such symptoms but is characterized by the 
formation of granulomas, the pathological hallmark of TB, an orderly aggregation of 
host immune cells around infected macrophages, not only in lung but also in many 
other tissues and organs. This response is initiated by the effect of mycobacterial 
virulence factors on host innate immune cells and progresses as the result of a 
concerted action of innate and adaptive immunity (84, 85). 
After Mtb infects the host, macrophages and neutrophils are the first line of host 
defense against its invasion. Macrophages recognize the pathogen associated 
molecular patterns (PAMPs) of pathogens through the surface exposed PRRs, which 
also bind bacteria to initiate phagocytosis. Phagocytosis is a hallmark of anti-bacterial 
host defense, subsequent engulfment of bacteria leads to formation of the phagosome 
through the invagination of the cell membrane. In the cytoplasm, the phagosome 
undergoes fusion with endosomal or trans-Golgi-derived transport vesicles and fission 
of vesicles (86). These processes are also modulated by Mtb bacteria which try to 
influence the fusion of vesicles and the acidification of the phagolysosome (87, 88).  
After recognition and phagocytosis of Mtb and their components, macrophages 
induce the production of various cytokines, such as TNF-α, IL-1β, IL-6 and IL-12, and 
chemokines, such as IL-8, which activates neutrophils releasing more IL-8, thereby 
attracting monocyte-derived macrophages and other immune cells like lymphocytes to 
the site of infection (86). These processes are concomitant with the development of 
granulomas (89). The granuloma development process proceeds either to localized 
eradication of the infection or to localized caseation and necrosis, culminating in 
bacterial release and leading to more infection (89).  
Autophagy as an alternative strategy of host defense against Mtb should also be 
mentioned. Autophagy targets ubiquitinylated organelles/proteins to the 
autophagosome, which fuses with lysosomes to generate an auto-phagolysosome (86). 
It has been shown that an essential autophagy control factor, called Atg5, plays an 
important role in defense against Mtb infection (90, 91). However, recent studies in 
mice indicate that conventional autophagy pathways are not essential for the control 
of tuberculosis and have linked the function of Atg5 to prevention of pathological 
inflammation during Mtb infection (92, 93). Therefore further studies are needed to 
investigate if other non-canonical autophagy pathways exist that control TB. 
In Mtb infection, TLR2 is a key innate immune receptor, dimerizing with TLR1 and 
gathering other accessory molecules like CD14, to recognize the specific cell wall 
components of Mtb, such as lipoproteins LpqH, LprA, LprG and PhoS1, Glycolipids 
lipoarabinomannan (LAM), lipomannan (LM), phosphatidylinositol mannoside (PIM) 






FIGURE 2 Immune cells activation in the presence of Mtb and stimulation of its signal transduction 
components. The strategies of host defense against Mtb infection include macrophage- and dendritic 
cell-mediated T cell responses, neutrophil-mediated killing of bacteria, granuloma formation, 
apoptosis mediated by neutrophils and macrophages and macrophage-mediated autophagy. Figure 
adapted from Hamza et al. (97). 
 
the TLR2 protein contributes to host defense against Mtb infection. In in vitro studies, 
lipoproteins or other Mtb cell wall components induce TLR2-dependent cytokines, 
chemokines, and nitric oxide production and stimulate dendritic cell maturation (15, 
98, 99) (Fig. 2). Through these actions, TLR2 mediates a nitric oxide-dependent or -
independent anti-mycobacterial activity (100, 101). TLR2 activation by agonists such as 
one of the mycobacterial unique PE family of proteins and the lipoprotein LpqH from 
Mtb also mediates autophagy (102) and macrophage apoptosis (103, 104), which also 
contributes to bacterial elimination and inhibition of proliferation. Lancioni et al. (105) 
also found that LprG and LpqH can directly regulate CD4(+) T cell activation in a 
TLR2/1 dependent way (105). The researchers from this group subsequently showed 





responses to Mtb infection in mice (106) (Fig. 2). in vivo studies also showed a role for 
TLR2 in protection against chronic Mtb in the murine model (107, 108). In addition, IL-
17 is required for early protective immunity against Mtb HN878 infection (109). Gopal 
et al. (109) showed that Mtb strain HN878 induces IL-17 production in an IL-1β-TLR2 
dependent way. Through IL-17 receptor signaling, IL-17 mediates CXCL-13 induction, 
which is required for localization of T cells in lymphoid follicles and for optimal 
macrophage activation and Mtb control (109).  
Immune evasion mediated by TLR2 
In contrast to a defensive function, TLR2 can also be exploited by Mtb to evade host 
immunity. Previous in vitro studies indicate that the prolonged incubation of 
macrophages with the mycobacterial lipoproteins LprA, LprG and LpqH resulted in 
TLR2-dependent inhibition or decrease of MHC-II antigen processing and presentation 
(16, 98, 110). This leads to a defective recognition of infecting bacteria by CD4(+) T cells 
and negatively influences the CD4(+) T cell responses and control of infection. 
Furthermore, also polarization of T helper type 1 (Th1) cells, which show a protective 
role in Mtb infection (111, 112) is influenced by TB infection. The polarization of Th1 
cells is promoted by the pro-inflammatory cytokines, such as IL-12, IFN-γ, TNF-α and 
influenced by the anti-inflammatory cytokines, such as IL-10 (113, 114). Richardson et al. 
(115) showed that the induction of IL-10, suppression of IL-12 and inhibition of MHC-II 
induced by Mtb infection in macrophages are driven by TLR2-dependent activation of 
ERK, which influences the Th1 polarization and thereby can contribute to immune 
evasion by the bacteria. In addition to these macrophage-mediated T cell responses, 
another possible strategy of host defense against Mtb is macrophage-mediated 
autophagy as described above (116). In vivo studies in mice show that autophagy 
activation can be inhibited by a microRNA, miR-125a, through targeting UV radiation 
resistance-associated gene (UVRAG) (117) and the expression of miR-125a is mediated 
by Mtb in a TLR2/Myd88 dependent way (117). These studies indicate that the 
exploitation of TLR2/Myd88 pathway to inhibit autophagy activation is another 
possible way of Mtb to evade host immunity. Similar to IL-10, another negative 
regulator of TLR signaling, A20, was also reported to participate in TLR2-mediated 
host immune evasion of Mtb in an indirect way (118). Kumar et al. (118) showed that 
A20 is the target of the microRNA miR-let-7, which is downregulated in Mtb-infected 
macrophages and enhances expression of A20, thereby attenuating inflammatory 
signaling and facilitating bacterial survival. 
Unlike TLR2, TLR4 does not show a controversial role in host defense against Mtb. 
Deficiency in TLR4 compromises host immunity. For instance, Tlr4 mutant mice show 
impaired macrophage recruitment and pro-inflammatory responses to Mtb infection, 





mutants also showed an increased mortality and mycobacterial proliferation in the 
lung (120). 
With regards to other TLRs, it is reported that TLR9 polymorphisms are associated 
with the host susceptibility to tuberculosis (121-123). Infected Tlr9 mutant mice display 
defective mycobacteria-induced interleukin IL-12p40 and interferon IFN-γ responses, 
indicating that Tlr9 may regulate Th1 responses in Mtb infection (124). It is worth 
noting that compared with Tlr2 or Tlr9 single mutants, Tlr2/9 double mutant mice 
displayed significantly enhanced susceptibility to Mtb infection, and a decrease in pro-
inflammatory cytokines production and altered pulmonary pathology (124). These 
results illustrate that TLRs collaborate together in host defense against Mtb invasion. 
In conclusion, TLRs not only show a function in innate immune responses to Mtb 
infection, but also show roles in mediating immune evasion (125-129). 
Study of mycobacterial infection in zebrafish 
Zebrafish has become a prominent vertebrate model to study human infectious disease, 
especially for TB (130, 131). First, because the natural fish pathogen, Mycobacterium 
marinum, a close relative to Mtb, can induce granuloma formation in adults and larvae 
of zebrafish. The granulomas in adult fish are very similar to those observed during 
human latent TB progression and zebrafish larvae provide unique access to the earliest 
stages of the formation of these granulomas (132, 133). Second, the relatively small size 
of embryos allows infection assays to be performed at a large scale. In addition, the 
transparent larvae are ideal for imaging the early steps of the infection process in real 
time. The short generation time of 3-4 months is useful for generating transgenic lines 
and other genetics approaches. Last but not the least, zebrafish have a 3-4 weeks 
separation stage between development of innate and adaptive immunity after 
fertilization (134, 135), which gives the possibility to study the host innate immune 
response to infection in the absence of adaptive immune responses. Zebrafish have 
lymphatics but lack lymph nodes, so the adaptive immune cells mainly develop and 
function in the spleen, the kidney and the thymus (131, 136-138). Furthermore, fish do 
not have bone marrow and instead the anterior part of the kidney functions as a major 
site of hematopoiesis. Anatomically, this is therefore different from mammals, but 
zebrafish shares most of the primary constituents of innate and adaptive immunity 
with mammals (136, 139, 140). Zebrafish larvae can only activate innate immunity to 
provide resistance against Mtb infection. The two most important immune cell types 
for the innate defenses, macrophages and neutrophils, are already functional from 1 
day post fertilization (dpf) (141-143). 
From previous work in our laboratory several examples can be given of how 
zebrafish research has helped to study immune cell mechanisms that function in 





macrophages is required for M. marinum phagocytosis and the pro-inflammatory 
response to infection (144, 145). Additionally, the macrophage perforin Mpeg1.2, a 
macrophage marker, is an infection inducible factor in macrophage defense against M. 
marinum (146). As described above, autophagy could be an important mechanism in 
macrophage defense. DNA damage-regulated autophagy modulator (Dram1) was 
demonstrated to augment this process in response to infection in zebrafish (147). 
Moreover, the stabilization of transcription factor hypoxia inducible factor 1α (Hif-1α) 
and the reduction of Hif-2α can enhance reactive nitrogen species (RNS) in neutrophils 
and decrease mycobacterial burden, and these processes are dependent on inducible 
nitric oxide synthase (iNOS) signaling at early stages of infection (148). Both Dram1-
mediated autophagy (147) and the production of RNS or reactive oxygen species (ROS) 
driven by mycobacteria (149) are dependent on the TLR signaling adaptor Myd88 and 
mutation of the myd88 gene in zebrafish severely impairs host innate immunity 
defense against mycobacterial infection in zebrafish (150).  
Overview of the TLRs in zebrafish  
Various orthologs of the mammalian TLRs have been identified in zebrafish and other 
fish species, such as Tlr1, 2, 3, 5, 7, 8 and 9 (151, 152). In addition to these orthologs, 
there are fish-specific Tlrs in zebrafish, such as Tlr19, 20, 21 and 22 (151, 152). 
Furthermore, some Tlrs, like Tlr4, Tlr5, Tlr8 and Tlr20, have two or more copies (151, 
152). Since the TLRs in fish have been recently reviewed very extensively, only a very 
brief summary of functional studies of Tlr4, Tlr5 and Tlr2 of zebrafish is given here.  
    There are two orthologs of Tlr4 in zebrafish, Tlr4a/Tlr4b, but different from the 
function of TLR4 in mammals, they do not recognize LPS (153, 154). This might be 
because of the absence of the crucial TLR4 accessory molecules Md2 and Cd14, which 
are essential for LPS binding in mammals. In mammals, the Md1/Rp105 complex has 
been shown to negatively regulate Tlr4-Md2-LPS binding (155, 156). In contrast, the 
Md1/Rp105 complex was found to participate in the regulation of innate immunity and 
viral resistance in zebrafish (157, 158). In addition, another functional component of 
the TLR4 complex, TLR4 interactor with leucine-rich repeats (Tril), was also identified 
in zebrafish (159). Chimeric Tlr4 molecules that consist of zebrafish extracellular LRR 
domains and mouse intracellular TIR domains demonstrated a lack of responsiveness 
to LPS (153). These studies indicate that Tlr4 might play a different role in mediating 
NF-κB activation in zebrafish that has not been described in mammals (154). On the 
physiological level, He et al. (160) demonstrated that Tlr4-Myd88-NF-κB signaling is 
both necessary and sufficient for hematopoietic stem and progenitor cell (HSPC) 






Studies of Tlr5 structure and function has determined its high conservation amongst 
vertebrates (161, 162). In zebrafish, Tlr5 possesses two orthologs-Tlr5a and Tlr5b, which 
are both involved in the recognition of flagellin as is the case with the single TLR5 
protein of mammals. In zebrafish, the Tlr5 genes are required for the activation of host 
specific defense genes upon Salmonella infection (162). Flagellin-Tlr5 signaling was 
also shown to be crucial for a mucosal immune responses in the zebrafish intestine 
induced by a live attenuated Vibrio anguillarum vaccine (163). Concomitant with the 
upregulation of other PRRs, such as Tlr2, Tlr4, Nod1, Nod2 and Marco, and adapters, 
such as Myd88, Irak4, Irf7 and Traf1/2b/3, it was shown that Tlr5 is significantly 
upregulated during infections by various bacterial species in zebrafish (163, 164). To 
elucidate the structural basis and mechanistic implications of TLR5-flagellin 
recognition, Yoon et al. (161) analyzed the crystal structure of zebrafish Tlr5 in complex 
with Salmonella flagellin. Recently, Amelia et al. (164) described the capacity of 
distinct flagellar serotypes to differentially activate Tlr5 in zebrafish. Tlr5 signaling 
could be potentially affected by single-nucleotide polymorphisms present within 
coding sequences for the conserved C-terminus of various flagellin variants, which 
directly contact with Tlr5 (164). These studies trigger the interests to further study the 
binding mechanism of Tlr5 with various flagellins.  
As in mammals, zebrafish Tlr2 also mediates pathological inflammatory injury. For 
example, the outer membrane protein of pathogenic leptospires, LipL32, can induce 
leukocyte infiltration and kidney injury in Tlr2 dependent manner in zebrafish (165). 
Despite its important role in infectious disease in mammals, further studies of TLR2 in 
zebrafish were lacking, and therefore this is an important subject of this thesis. These 
studies show that zebrafish are a valuable addition to mammalian models for 
understanding the function of TLR2 in infectious disease. 
Outline of this thesis: 
In Chapter 2 we applied RNA deep sequencing (RNAseq) analysis to comparatively 
study the systemic transcriptome responses in whole zebrafish embryos upon injection 
with TLR2 agonist- Pam3CSK4 and TLR5 agonist-flagellin. We describe the genes 
whose transcription shows an early response to these PAMPs. In addition, we describe 
a set of genes that show a specific immune response via the function of tlr2 but not by 
tlr5, such as cebpb and fosb. 
    In Chapter 3, we analyzed a tlr2 null mutant zebrafish line. We applied the M. 
marinum infection model in the zebrafish tlr2 mutant larvae to study Tlr2 function in 
the innate immune system during infection. The tlr2 mutant showed a reduced 
macrophage number in the absence of infection, but higher migration speed and 
maximum migration distance from infection sites of phagocytic macrophages. The tlr2 





that M. marinum infection of the tlr2 mutant leads to decreased responses to infection 
at the mRNA level of genes involved in inflammation and immunity, especially the Tlr2 
specific genes described in Chapter 2. Moreover, our transcriptome analysis revealed 
Tlr2-specific pathways involved in M. marinum infection, which are also related to 
responses to M. tuberculosis infection in human macrophages. 
The zebrafish model can also assist with the analysis of the mechanisms of TLR 
downstream signaling as we show in Chapter 4. In this chapter we show that TLR 
downstream signaling pathways are also important for research of metabolic 
syndromes such as diabetes type II. We analyzed zebrafish Traf6 and Ikk2 mutants 
with a stop codon in the reading frame of the proteins (traf6sa244/sa244 and ikk2m10/m10 ). 
There were no consistent indications for effects on leukocytes phenotype and bacterial 
burden upon M. marinum infection in traf6sa244/sa244. In contrast, ikk2m10/m10 larvae 
showed a significant decrease in body size, leukocyte numbers and expression of 
marker genes for macrophages and neutrophils. Upon M. marinum infection, 
ikk2m10/m10 larvae also showed a higher bacterial burden, which indicates that Ikk2 plays 
a role in host defense against infection. In addition, in the ikk2 mutant the insulin 
resistance induced by hyperinsulinemia was modulated. Considering the phenotype of 
the ikk2 mutant in both infection and insulin resistance this mutant provides new 
possibilities to further study the connection of innate immunity and metabolic 
diseases. 
Finally, Chapter 5 contains a general discussion and summary of the work described 
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Although the responses to many pathogen associated molecular patterns (PAMPs) in 
cell cultures and extracted organs are well characterized, there is little known of 
transcriptome responses to PAMPs in whole organisms. To characterize this in detail, 
we have performed RNAseq analysis of responses of zebrafish embryos to injection of 
PAMPs in the caudal vein at one hour after exposure. We have compared two ligands 
that in mammals have been shown to specifically activate the TLR2 and TLR5 receptors: 
Pam3CSK4 and flagellin, respectively. We identified a group of 80 common genes that 
respond with high stringency selection to stimulations with both PAMPs, which 
included several well-known immune marker genes such as il1b and tnfa. Surprisingly, 
we also identified sets of 48 and 42 genes that specifically respond to either Pam3CSK4 
or flagellin, respectively, after a comparative filtering approach. Remarkably, in the 
Pam3CSK4 specific set, there was a set of transcription factors with more than 2 fold-
change, as confirmed by qPCR analyses, including cebpb, fosb, nr4a1 and egr3. We also 
showed that the regulation of the Pam3CSK4 and flagellin specifically responding sets 
is inhibited by knockdown of tlr2 or tlr5, respectively. Our studies show that 
Pam3CSK4 and flagellin can stimulate the Tlr2 and Tlr5 signaling pathways leading to 
common and specific responses in the zebrafish embryo system.  
 
Introduction 
The innate immune system is referred to as the first line in host defense against 
invading pathogens (1, 2). Its highly developed ability to recognize microbial patterns 
and host-derived danger signals relies on so-called pattern recognition receptors 
(PRRs), especially on the Toll-like receptors (TLRs) (3-5). In humans, the TLR family is 
composed of 10 members, which are located at the cell surface with the exception of 
TLR3, 7, 8 and 9, which are localized on intracellular endosomal membranes (6-8). The 
TLRs are involved in the recognition of a wide variety of ligands, including pathogen 
associated molecular patterns (PAMPs), such as bacterial cell wall components and 
viral RNA, as well as damage associated molecular patterns (DAMPs) (9, 10). This leads 
to subsequent intracellular signal transduction, triggering the production of 
inflammatory cytokines and chemokines, but it can also lead to anti-inflammatory 
responses as has been recently shown for TLR10 acting as a heterodimer with TLR2 (11, 
12).  
    The recognition of PAMPs and DAMPs by different TLRs is directed by structurally 
conserved leucine-rich repeats (LRR) motifs of the TLRs ectodomains (ECDs) (13, 14). 
Cell-surface TLRs can mediate binding to PAMPs by homodimerizing, like TLR4 and 
TLR5 that recognize lipopolysaccharide (LPS) (15) and flagellin (16), respectively. In 





TLR10, in conjunction recognizing lipopeptides and lipoproteins (12, 17, 18). The 
diversity of TLR2 dimer combinations is thought to be responsible for its extensive 
recognition ability, ranging from the diverse components of various pathogens to the 
host heat-shock protein 70 (10). TLR2 plays an important role in resistance to the 
infection induced by Mycobacterium tuberculosis (Mtb) (19, 20). For example, McBride 
et al. demonstrated that TLR2 knockout mice show enhanced cell infiltration and 
inflammation in lungs upon low dose chronic infection with Mtb, and fail to stably 
control the bacterial burden (21). A series of components of Mtb can trigger the TLR2 
signaling pathway upon infection, such as tri-acylated lipoprotein LprG, LpqH and 
PhoS1 (22, 23), and glycolipid lipo-arabinomannan (24). Pam3CysSerLys4 (Pam3CSK4) 
is a synthetic tri-acylated lipopeptide that mimics the triacylated lipoprotein of 
mycobacteria and classical gram-positive bacteria, which can be recognized by 
TLR2/TLR1 heterodimers and induce the production and release of pro- and anti-
inflammatory cytokines (IL-6, IL-12, TNF-α and IL-10), chemokines (IL-8) and 
interferon (IFN-γ) (25-28). Most of these studies on the responses of the TLR2 signaling 
pathway have been performed in cell culture systems. A notable exception is the 
reported transcriptome response of mouse mononuclear phagocytes recruited to lungs 
challenged with Pam3CSK4 as measured by micro-arrays (29). As another example 8-
day old mice were treated with Pam3CSK4 and analyzed for the expression of several 
inflammatory genes using qPCR (30). 
    The zebrafish embryonic model has much potential to study the ligand specificity of 
TLRs at the organism level [29]. Importantly, zebrafish offers the possibility to study 
the innate immune system separated from the adaptive immune system in their 
embryonic and larval stages (up to 3-4 weeks post fertilization) (31-33). To date, a 
number of TLR signaling pathway mediators have been identified and studied in 
zebrafish such as the adaptor proteins Myd88, Tirap (Mal), Trif and Sarm1 (34-38), and 
the downstream signaling intermediates Irak and Traf6 (39, 40).  
    In work previously published by our group, we demonstrated that the function and 
regulation of the zebrafish homologs of human TLR5, tlr5a and tlr5b, are conserved 
with their mammalian counterparts. Both tlr5a and tlr5b are strongly up-regulated in 
response to Salmonella typhimurium infection (41). Furthermore, in the same study it 
was shown that knockdown of these two genes prevented or weakened the activation 
of genes for several inflammatory mediators like mmp9, cxcl-C1c, il1b and il8 upon 
flagellin stimulation (41).  
In this study, we aimed to study TLR2 function, in comparison with TLR5, in 
zebrafish using transcriptome analysis. Injection into the blood stream of the tlr2/tlr1 
ligand Pam3CSK4, was followed by transcriptome profiling to characterize key genes 
involved in the early response to this PAMPs. In addition, by comparing the 





non-specific immune responsive genes from a set of genes which are regulated by tlr2 
but not by tlr5.  
 
Results  
1 The immune response of zebrafish embryos to injection of PAMPs in the caudal vein 
In a recent study by Stockhammer et al, it was shown that flagellin injected into the 
caudal vein at 27 hours post fertilization (hpf) induced several immune response 
marker genes as measured by qPCR (41). To further characterize the response to 
another well characterized PAMP, we injected Pam3CSK4 using the same method. The 
expression levels of cytokine genes il1b, tnfa and il6, the chemokine gene il8, and anti-
inflammatory gene il10, were measured by qPCR at 1, 3 and 6 hour post injection (hpi) 
respectively (Fig. 1). The results show that there was a significant up-regulation of 
these genes upon Pam3CSK4 stimulation. For all these marker genes the induction was 
transient and followed by a gradual decrease over time. The il1b gene was the only 
marker of which up-regulation was observed at 1 and 3 hpi, with a significantly higher 
expression than the control group (Fig. 1A). For the tnfa, il6, il8 and il10 genes there was 
a more obvious decrease of induction over time (Fig. 1B-E). These results show that 
Pam3CSK4 induces similar responses in zebrafish as in mammalian cells (25-28) 
suggesting that this response is also mediated via the tlr2 signaling pathway.  
 
2 The function of Tlr5 and Tlr2 in the immune response towards flagellin and Pam3CSK4 
In order to study the function of tlr2 and tlr5 in the above described responses to 
Pam3CSK4 and flagellin we used morpholinos to knockdown these genes. There are 
two orthologous genes of human tlr5 in zebrafish, tlr5a and tlr5b and previous studies 
in our group showed that they are required for activation of host defense genes upon 
flagellin stimulation. This was shown by simultaneous co-knockdown of tlr5a and tlr5b 
by morpholinos (41). In this study, tlr5a and tlr5b morpholinos were injected separately 
and, subsequently the morphants were stimulated with flagellin at 27 hpf. Embryos 
treated with standard control morpholino were used as a control (41). The expression 
of il1b was measured at 1hpi by qPCR. Our results revealed that abrogation of both tlr5a 
and tlr5b effectively prevented the il1b up-regulation observed in control embryos upon 
flagellin stimulation (Fig. 2A).   
    The function of tlr2 in recognition of Pam3CSK4 was tested in the same manner. Our 
results showed that tlr2 morphants did not exhibit up-regulation of il1b expression 






FIGURE 1 Immune genes expression at different time points upon Pam3CSK4 stimulation. Embryos 
were injected at 27 hpf with 1ng Pam3CSK4 and expression levels of il1b (A), il8 (B), tnfa (C), il10 (D) 
and il6 (E) were determined at 1, 3 and 6 hours post injection by qPCR. Data (mean + SEM) are 
combined from at least three biological replicates (n=15 embryos per group) and expressed relative 
to their corresponding mock injection (water) control, which is set at 1. Statistical significance of 
differences between mock and Pam3CSK4 groups was determined by ANOVA analysis and Tukey’s 






FIGURE 2 il1b expression in tlr2 and tlr5 morphants following PAMPs stimulation. Embryos were 
injected at the 1-2 cells stage with standard control (Sc), tlr2, tlr5a or tlr5b morpholino (MO) and 
subsequently injected with Pam3CSK4 at 27 hpf, flagellin or water as a mock control. Expression of 
il1b was determined by qPCR at 1 hpi. A, tlr5a and tlr5b knockdown effect on il1b RNA expression in 
response to flagellin. B, C tlr2 knockdown effect on il1b RNA expression in response to Pam3CSK4 (B) 
or flagellin (C). Data (mean + SEM) are combined from at least three biological replicates (n=10 
embryos per group) and expressed relative to their corresponding water control, which is set at 1. 
Statistical significance was determined by ANOVA analysis and Tukey’s multiple comparisons test, 









tlr2 morphants stimulated with flagellin, still showed a significant induction of il1b 
expression (Fig. 2C).  
 
3 Identification of a common response gene set for Pam3CSK4 and flagellin stimulation 
Since comparisons of the transcriptome response to PAMPs that activate different 
TLRs has not been described before in a whole organism we decided to perform RNA 
deep sequencing (RNAseq) of embryos treated with flagellin and Pam3CSK4 at 1 hpi.  
    Embryos injected with sterile water were used as control and RNA was isolated from 
a pool of at least fifteen embryos per condition. Triplicates of biological samples were 
analyzed with Illumina RNAseq and at least 7.2 million mapped reads were obtained 
for each library (Fig. 3A, Supplemental table IV). Although such reads numbers are 
insufficient to detect changes in very lowly expressed genes (see Veneman et al, 2014 
(42)) approximately 10 million total reads is currently a good cost efficient number that 
matches the sensitivity of microarrays (43). The results of the transcriptional responses 
are summarized in Fig. 3A and Supplemental Fig. 1. The results show that at any given 
p-value (or false discovery rate-adjusted p-value), flagellin leads to a higher number of 
differentially expressed genes (DEGs) than Pam3CSK4. To further analyze the data, we 
arbitrarily used a threshold of 2-fold change and p-value <0.01. This p-value 
corresponds to FDR adjusted p-values ranging from 0.23 to 0.35 in the different 
experiments. These selection criteria are not very stringent so as to prevent loosing 
genes that are very lowly expressed and therefore with the used sequencing depth will 
have obtained only low numbers of reads. The entire list of responses without any 
selection criteria is given in Supplemental tables V and VI. Applying these settings we 
obtained 264 DEGs from the Pam3CSK4 stimulated group, composed of 169 up- and 95 
down-regulated genes, and 306 DEGs from the flagellin injected group, composed of 
180 up- and 126 down-regulated genes (Fig. 3A). Therefore, with both treatments there 
are more genes up-regulated than down-regulated. In the list of top induced and 
repressed genes there is a lack of any annotation in the data bases (supplemental table 
V and VI). We compared these two groups of genes and found an overlap set of only 80 
genes that include many immune marker genes, such as il1b, tnfb, irak3 and irg1l, and 
transcription factors, like fos, fosl2 and junba, as shown by the gene ontology terms 
(GO terms) annotation in Fig. 3B and Supplemental table III.  
The induction of il1b, tnfa and il8 by Pam3CSK4 shown using qPCR (Fig. 1) was 
confirmed by the RNAseq data (Fig. 3C), but in the case of il6 and il10 there was no 







FIGURE 3 RNAseq experimental setup and comparison of gene sets responsive to Pam3CSK4 or 
flagellin stimulation. A, setup of the RNAseq experiment. Zebrafish embryos received a 1nl injection 
of 1 mg/ml Pam3CSK4 and 100 μg/ml flagellin respectively into the caudal vein at 27hpf. Control 
embryos were injected with water. Samples for RNAseq were taken at 1hpi. The numbers of 
differentially expressed genes were assessed by two criteria: 1) p<0.01, 2 fold-change or 2) adjusted 
p-value <0.01, without FC cut-off. B, Venn diagram showing the overlap between DEGs from 
Pam3CSK4 and flagellin stimulations and their GO terms annotation. C, Fold-change values of 
inflammatory genes in RNAseq. D, Filtering of 264 DEGs from Pam3CSK4 stimulation (p<0.01, 2 fold-
change) by the flagellin non-specific set (22611 genes, p>0.05; <1.4-fold change) results in 48 
Pam3CSK4 specific genes, which are grouped according to their GO terms annotation. E, Filtering of 
306 DEGs from flagellin stimulation (p<0.01, 2 fold-change) by the Pam3CSK4 non-specific set (22391 
genes, p>0.05; <1.4-fold change), results in 42 flagellin specific genes, which are grouped according 












FIGURE 4 qPCR analysis of transcription factors genes responsive to PAMPs stimulation. Expression 
levels of fosl1a, fosb, junbb, cebpeb, egr3 and nr4a1 following Pam3CSK4 and flagellin stimulation are 
determined by qPCR. Data (mean + SD) are combined from at least tree biological replicates (n=15 
embryos per group) and expressed relative to their corresponding water control, which is set at 1. 
Statistical significance was determined by two-way ANOVA analysis and Tukey’s multiple 
comparisons test, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.  
 
4 Identification of gene sets that are specifically regulated by Pam3CSK4 and flagellin 
This study unexpectedly revealed that there is a relatively large group of genes that are 
only induced or repressed by either Pam3CSK4 or flagellin (Fig. 3B). To further test 
whether this specifically induced group is completely unaffected by the other PAMP 
treatment we used a rigorous filtering approach as shown in Fig. 3D and E. For this 
approach, the DEGs from the Pam3CSK4 (264 genes) and flagellin (306 genes) 
stimulation groups were compared with the group of genes that were not affected by 
flagellin (22611 genes) and Pam3CSK4 (22391 genes), respectively, with a cut-off setting 
at <1.4-fold change and p>0.05. By taking the overlap of these sets we thereby exclude 
genes that were inducible by the other ligand even at very low stringency. This resulted 
in a set of 48 genes (Fig. 3D) for which the response is specific to Pam3CSK4 and a set 
of 42 genes (Fig. 3E) for which the response is specific to flagellin. GO analysis 
indicated that these two groups contain different categories (Fig. 3D, E). Most notably, 
genes with high fold-change (>2) from the Pam3CSK4 specific group include many 





fosl1a, egr3 and nr4a1. In the flagellin specific group of genes this is not the case and an 
obvious enriched category could not be identified.  
To confirm the result of deep sequencing, qPCR was performed to verify the 
responses of genes from the Pam3CSK4 specific gene set, namely junbb, cebpb, fosb, 
fosl1a, egr3 and nr4a1 (Fig. 4). As expected, the expression level of all these 
transcription factors confirmed the deep sequencing result. Moreover, these genes did 
not exhibit an apparent differential expression in zebrafish upon flagellin stimulation 
except fosl1a and junbb (Fig. 4). Even though the expression of these both genes 
showed significant induction upon flagellin stimulation, the induction level was still 
far lower than that upon Pam3CSK4 stimulation.  
 
5 Function of the tlr2 and tlr5a genes in the transcriptome responses to Pam3CSK4 and 
flagellin 
To confirm that the transcriptome responses upon PAMPs stimulation described above 
(Fig. 3B and Fig. 4) are tlr2 or tlr5 specific, we performed RNAseq analyses of the 
Pam3CSK4 and flagellin responses under tlr2 and tlr5a knockdown conditions, again 
using biological triplicates of each group. Setting a threshold of 2 fold-change and 
p<0,01, we found that the 80 common DEGs responsive to both Pam3CSK4 and 
flagellin were reduced by tlr2 and tlr5a knockdown (Fig. 5C, D). Furthermore, all the 
48 genes (40-up and 8-down-regulated) from the Pam3CSK4 specific group showed no 
longer a differential expression or an anti-correlated expression after tlr2 knockdown 
and, similarly all the 42 genes (24-up and 18-dow-regulated) from the flagellin specific 
group showed no longer a differential expression or an anti-correlated expression upon 
tlr5a abrogation (Fig. 5A, B). Overall, these results confirm the specificity of both 
morpholinos and show that zebrafish tlr2 and tlr5a are key mediators of the 











FIGURE 5 Effects on tlr2 and tlr5 knockdown on the expression of Pam3CSK4 and Flagellin responsive 
genes. A, based on RNAseq data, all the 48 Pam3CSK4 specific genes are inhibited or down-regulated 
in tlr2 morphants (tlr2 MO) upon this PAMP stimulation. B, based on RNAseq data, all the 42 flagellin 
specific genes are inhibited or down-regulated in tlr5a morphants (tlr5a MO) upon this PAMP 
stimulation. C, D, all the 80 common genes are inhibited or down-regulated in tlr2 and tlr5a 
morphants. FC, fold-change. Panel A, B, C, D: for the quantitative data and accession numbers of the 
shown genes (or numbers) we refer to Supplemental table II (panel A), III (Panel B) and IV (panels C 









The signaling pathways underlying recognition of PAMPs have been studied 
intensively and this has led to a broad understanding of key regulators of innate 
immunity based on studies of cell cultures and the use of knockout rodent mutants. 
The new possibilities for analysis of transcriptomes using RNA deep sequencing make 
it highly attractive to analyze the responses of an entire test animal model at the 
system biology level. In this manuscript we have chosen the zebrafish embryo model 
for such an approach and have included functional analysis of Tlr5 and Tlr2 in the 
response towards two well-known PAMPs, flagellin and Pam3CSK4.  
The results show that there is a relatively limited overlap between the transcriptome 
responses towards flagellin and Pam3CSK4 (Fig. 3B). The overlap includes well known 
downstream immune mediators that were previously shown to be induced by flagellin 
(41) such as il1b, tnfa, irak3, mmp9, cxcl-c1c and il8. In contrast, il6 and il10, that are 
associated with an anti-inflammatory response, were induced much stronger by 
Pam3CSK4 than by flagellin. A relatively much larger group of genes showed a 
differential response to flagellin or Pam3CSK4, including a group of genes of which the 
transcription is specific for activation by one of the two treatments (Fig. 4).  
GO terms analysis of the genes specifically regulated by these two PAMPs show that 
there is an enriched category of transcription factors in the Pam3CSK4-specific group, 
of which most of genes are up-regulated and only one is down-regulated. Additionally, 
a less enriched category of immune response genes is found in this group as well, 
which include a down-regulated CRP (C-reactive protein). For the flagellin-specific 
group of genes, there are only five genes under the GO-term regulation of transcription 
of which two are down-regulated. Many of the genes specifically induced by 
Pam3CSK4 have also been shown to be strongly regulated by infection in the zebrafish 
embryo system (44) and therefore we would like to further study this group of genes in 
more detail in future research. 
    For functional analysis of the transcriptome response towards flagellin and 
Pam3CSK4 we used morpholinos that were selected on basis of their blocking effect on 
downstream signaling using qPCR and subsequently confirmed by RNAseq analysis. 
Surprisingly for tlr5 we found that a morpholino against each of the two copies of this 
gene, tlr5a and tlr5b had an effect on downstream signaling, with the tlr5a morpholino 
giving a complete block of induction of il1b by injection with flagellin and a partial 
effect of the tlr5b morpholino. These data suggests that these two tlr5 copies function 







FIGURE 6 Specific and common responses to Tlr2 and Tlr5 ligands. The whole organism transcriptome 
response of zebrafish embryos to treatment with the Tlr2 ligand Pam3CSK4 or the Tlr5 ligand flagellin 
results in the induction of specific and common transcription factor genes as indicated in the figure. 
The common transcription factor genes (in cooperation with other non-inducible factors, e.g. of the 
NF-κB family), likely function upstream of the effector genes commonly induced by Pam3CSK4 and 
flagellin. The transcription factor genes induced by only one of the two ligands are likely to 
contribute to further specificity in the transcriptional responses of downstream effector genes.  
 
    An important question that comes from our work is how to explain the difference in 
gene sets that are regulated in response to Pam3CSK4 and flagellin? (Fig. 6) Since our 
detection system seems sufficiently sensitive to detect even minor effects on gene 
transcription, a limitation in dosing is not a likely explanation for this difference, so 
instead we think of another two possible alternative explanations. In the first place we 
could speculate that there are specific downstream signaling partners for Tlr2 and Tlr5. 
However, such partners have not yet been indicated by previous studies, in contrast, 
there are evidences that all known direct binding partners are common for both Tlr5 
and Tlr2 proteins: including the adaptor proteins Myd88, and Tirap (Mal) that have 
been implicated in signaling of both proteins (45). Furthermore, the functions of these 
genes in the direct recognition of TLR2 and TLR5 ligands have not been tested yet in 
whole animal models. Mutants for Tirap have not been described yet in zebrafish 
making the specific function of this gene currently difficult to investigate. Another 
possible explanation is that the differential response of zebrafish embryos to these two 
PAMPs is the result of an additive effect of the recognition by different cell types. In 
this case, the common group of activated downstream genes might be encoded by the 





whereas the specific response might be the result of a distinct transcriptional response 
of specialized cells that do not encode all Tlr receptors. The detailed study of these 
transcription factors will provide valuable information on the specific immune 
transcriptional signatures elicited by different pathogens. For this purpose the genetic 
tractability of the zebrafish system will allow the generation of new reporter lines that 
will contribute to the understanding of how these responses modulate the innate 
immune system. In addition, such reporter lines will be of general interest since 
Pam3CSK4 and flagellin signaling pathways are broadly used to study the Tlrs function 
in inflammatory microbial infection. Furthermore, this signaling pathway is also 
relevant for studies of atherosclerosis and autoimmune diseases processes (46, 47). 
Therefore the used systemic approach can be highly useful for future studies of a broad 
spectrum of immune-related diseases.  
 
Material and methods 
Zebrafish husbandry  
Wild-type zebrafish of the AB/TL strain were handled in compliance with the local 
animal welfare regulations and maintained according to standard protocols (zfin. org). 
Embryos were raised in egg water (60g/ml Instant Ocean sea salts) at 28.5 °C. For the 
duration of bacterial injections, embryos were kept under anesthesia in egg water 
containing 0.02% buffered 3-aminobenzoic acid ethyl ester (Tricaine). The breeding of 
adult fish was approved by the local animal welfare committee (DEC) of the University 
of Leiden. All protocols adhered to the international guidelines specified by the EU 
Animal Protection Directive 2010/63/EU.  
Morpholino injections  
Morpholino oligonucleotides (Gene Tools) were diluted to desired concentrations in 1× 
Danieu’s buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca (NO3)2, 5.0 mM 
HEPES (pH 7.6)) containing 1× phenol red (Sigma-Aldrich). For knockdown 
experiments, tlr2 ATG-morpholino (tlr2 mo, Supplemental table I) was injected with 
the optimal concentration at 0.5 mM and 1nl volume per embryo at 0~2 cell stage. tlr5 
translation was blocked via injecting 1nl of the tlr5a and tlr5b ATG-morpholinos at a 
dose of 0.1 mM and 0.5 mM at 0~2 cell stage, as previously published by Stockhammer 
and coworkers (41). Control embryos were injected with the standard control 
morpholino (Sc mo, Supplemental table I).  
Ligands injection 
For the ligands injection assay, purified Pam3CSK4 (InvivoGen) and flagellin from S. 





mg/ml and 100 μg/ml in sterile water. For their administration, 1 nl of the ligands was 
injected into the blood stream at 27 hpf, and sterile water was used as control. 
Injections were perormed using a FemtoJet microinjector (Eppendorf) and a 
micromanipulator with pulled microcapillary pipettes.  
RNA isolation, cDNA synthesis and qPCR 
RNA was extracted using TRIzol Reagent (Life Technologies) and purified by column 
according to the manufacturer’s instructions of RNeasy MinElute Cleanup Kit (Qiagen). 
The concentration and quality of RNA were detected by NANODROP 2000/2000c 
(Thermo Scientific). 1μg cDNA synthesis reactions and qPCR were performed as 
described in the manufacturer’s instructions (iScript™ cDNA Synthesis Kit and iQ™ 
SYBR® Green Supermix, BioRad) and normalized against the expression of ppial as a 
housekeeping gene (48). PCR analysis was performed using the following protocol: 
95°C 3 min, 40 cycles real time of 95°C 15 sec and 60°C 45 sec, and final melting curve 
of 81 cycles from 95°C 1 min to 55°C 10 sec. Results were analyzed using the ΔΔCt 
method. Primer sequences used can be found in Supplemental table I.  
Deep sequencing and data analyzing  
Triplicates of 10~20 embryos of AB/TL or tlr morphants from three injection conditions, 
Pam3CSK4, flagellin or water injection, were homogenized in 500 μl of Trizol reagent 
(Qiagen). Total RNA was extracted and column-purified according to the 
manufacturer’s instructions of the RNeasy MinElute Cleanup Kit (Qiagen). The 
subsequent sample preparation and Illumina RNA sequencing were as previously 
described (49). RNA samples were treated with DNaseI (Life Technologies) to remove 
residual genomic DNA. RNA integrity was analyzed by Lab-on-a-chip analysis (Agilent, 
Amstelveen, The Netherlands). A total of 2 μg of RNA was used to make RNAseq 
libraries using the Illumina TruSeq RNA Sample Preparation Kit v2 (Illumina, Inc., San 
Diego, CA, USA). The manufacturer's instructions were followed with the exception of 
two modifications. In the adapter ligation step, 1 μl, instead of 2.5  μl, adaptor was used. 
In the library size-selection step, the library fragments were isolated with a double 
Ampure XP purification with a 0.7× beads to library ratio (Beckman Coulter, Woerden, 
The Netherlands). The resulting mRNAseq library was sequenced using an Illumina 
HiSeq2500 Instrument (Illumina, Inc.) according to the manufacturer's instructions 
with a read length of 2×50 nucleotides. Image analysis and base-calling were done 
using the Illumina HCS version 2.0.12. The raw data has been submitted to the GEO 
database (accession number GSE64570). The total number of reads for each sample is 
summarized in supplemental table IV and quality control was according to the 
sequencing company guidelines (ZF-sceens.com). The data was analyzed using the 
GeneTiles software (http://www. genetiles. com) (42)using a cut-off setting of 2 fold-





Bowtie2 (50) to align the reads to the zebrafish genome (obtained from Ensembl 
version Zv9). Subsequently, the programs SAMtools (51), DESeq and DEXSeq (52, 53) 
are used for data processing. The complete data processing pipeline for Genetiles, 
including the used parameters, is available for download at www.genetiles.com and 
can also be found in Veneman et al (42). Using these settings we have mapped the 
numbers of reads as shown in Supplemental table IV. The triplicate data sets of 
Pam3CSK4, flagellin and control treatments were mapped to 27104, 26583, and 26409 
ENSEMBL genes, respectively. The difference between the mapped reads of the 
individual samples compared with the mapped reads of triplicate samples was always 
lower than 12 % (Supplemental table IV). GO analysis was performed using the 
software package DAVID available at http://david.abcc.ncifcrf.gov/home.jsp (54). 
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TLR2 is known to play controversial roles in host defense against pathogens, especially 
Mycobacterium tuberculosis (Mtb). To study the function of TLR2 in mycobacterial 
infection, we analyzed a tlr2 zebrafish mutant and infected larvae with Mycobacterium 
marinum (Mm), a close relative to Mtb, as a model for tuberculosis. After Mm infection, 
bacteria proliferated in tlr2-/- fish more than in the heterozygote tlr2+/-, suggesting that 
Tlr2 is involved as a protective factor in host defense. We observed a reduced number 
of granulomas in tlr2-/- larvae when compared to the control. We also found that the 
tlr2 mutant (tlr2-/-) shows a reduced number of macrophages in the absence of 
infection. However, the macrophage migration speed and maximum migration 
distance from infection sites of phagocytic macrophages, are significantly higher in 
tlr2-/- than in tlr2+/- larvae. These results suggest that Tlr2 might be playing a role in 
macrophage congregation and phagocytosis. RNAseq analysis of infection experiments 
in mutant versus control showed that the number of upregulated and downregulated 
genes in the control was greatly diminished in the tlr2 mutant, with the strongest 
effect on the down-regulated gene set. Detailed gene expression analysis using RNAseq 
and qPCR showed that Mm infection of tlr2 mutant leads to decreased mRNA levels of 
genes involved in inflammation and immune responses, including il1b, tnfb, cxcl11aa/ac, 
fosl1a and cebpb. Furthermore, RNAseq analysis revealed that genes for Maf family 
transcription factors (Mafb/c-Maf), vitamin D receptors (Vdr) and diverse 
immunoglobulin domain-containing proteins (Dicps) are significantly different 
regulated in tlr2 mutants with or without infection. This could result from a function 
in the control of induction of cytokines and chemokines as well as macrophage 
number, migration and phagocytosis. Moreover, our transcriptome analysis revealed 
Tlr2-specific pathways involved in Mm infection, which are also related to responses to 
Mtb infection in human macrophages. The expression analyses give further support for 
a function of TLR2 in host defense. 
 
Introduction  
Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis (TB), which 
infects nearly one-third of the world's population, and kills about 1.5 million people 
annually (WHO Global Tuberculosis Report 2015). TB is characterized by the 
formation of granulomas not only in the lung but also in other tissues and organs. This 
is the result of a concerted action of host innate and adaptive immunity (1, 2).  
Innate immune responses play a critical role in defense against TB infection in the 
host, and for a major part these processes are mediated by Toll-like receptors (TLRs), a 
conserved family of pattern recognition receptors. TLR2 is one of the most widely 





of its recognition of cell wall-associated components associated with this pathogen (3-
6). Following mycobacterial infection in human cell cultures, TLR2 dimerizes with 
TLR1 or TLR6, and recognizes mycobacterial components such as cell wall glycolipids 
LAM and LM (7), 38-kDa and 19kD mycobacterial glycoprotein (LpqH) (8-10), 
phosphatidylinositol mannoside (PIM) (11), and triacylated (TLR2/TLR1) (12, 13) or 
diacylated (TLR2/TLR6) lipoproteins (14, 15). Then these heterodimers recruit the 
Myd88 and Tirap (Mal) proteins to activate the IRAK(1 and 4)/TRAF6/IKK(α or β) 
cascade, which subsequently leads to the ubiquitination of IκBα and the activation of 
transcription factor NF-κB or AP-1 to release cytokines and chemokines (16, 17). Finally, 
these cytokines and chemokines attract migration of macrophages and neutrophils to 
the infection site leading to phagocytosis of bacteria. Tlr2 is shown to be a factor that is 
needed for granuloma formation in Mtb infection (18). Some studies have reported 
that Tlr2-/- mice lose control to high dose infection of Mtb or show higher 
susceptibility to Mtb infection compared to the wildtype (19, 20). Tlr2 also mediates 
the inhibition of MHC-II expression on the macrophage surface and MHC-II antigen 
processing by Mtb bacilli, thereby preventing presentation of Mtb antigens and 
decrease recognition by CD4+ T cells, which may allow intracellular Mtb to evade 
immune surveillance and maintain chronic infection (10, 21). The interaction between 
TLR2 and Mtb or other pathogens not only promotes the killing of bacteria, but also 
seems to be a part of the bacterium’s strategy to evade the immune system (22-24). For 
instance, LprG from Mtb was reported to inhibit human macrophage class II MHC 
antigen processing through TLR signaling (22). Furthermore, Tlr2 mutants of mice 
have an increased resistance against infection of Candida albicans (25) and Yersinia 
pestis (26). It has been proposed that this is the result of Tlr2-dependent induction of 
the anti-inflammatory cytokine IL-10 (26). Furthermore, TLR2 activation inhibits the 
release of IL-12 via activation of the cFos transcription factor. It also has been shown 
that IFN-γ or IFN-γ-induced signals (27) are inhibited after infection of murine 
macrophages in a Tlr2-dependent fashion (28). These effects show that TLR2 activation 
can yield a bias to T helper Type 2 (Th2) cells (29), and by breaking the Th1/Th2 
balance can lead to less Th1 type responses and reducing the killing of intracellular 
pathogens. However, most of the molecular mechanisms underlying TLR2 functions 
remain unknown and a better understanding of the TLR2-mediated immune response 
and immune evasion can help in planning prevention and therapy strategies against 
Mtb infection. 
Animal models have shown their power in studies of the mechanisms of interaction 
of host and TB pathogens, and discovering new anti-TB drugs. Zebrafish –adult and 
larvae– models have become a prevailing complement for rodent studies, for three 
important reasons. First, zebrafish have a 3-4 weeks separation stage between 
development of innate and adaptive immunity after fertilization (30, 31), which gives 





adaptive immune responses. Second, zebrafish can be infected by Mycobacterium 
marinum (Mm), a natural pathogen of cold blooded vertebrates and a close relative of 
Mtb, which can induce granuloma formation in zebrafish, and this is similar to human 
TB symptoms (32, 33). Third, the transparent larvae are ideal for imaging the early 
steps of the infection process in real time. Hence, zebrafish has earned its place of 
being a versatile tuberculosis model (34). In our previous study, we demonstrated that 
the mammalian TLR2 ligand Pam3CSK4, a synthetic triacylated lipopeptide that 
mimics the triacylated lipoprotein of mycobacteria, could also specifically activate the 
zebrafish Tlr2 pathway, inducing fosl1a and cebpb gene upregulation (35). 
In the current study, to further explore the involvement of Tlr2 in Mm infection, we 
conducted infection studies using tlr2 mutant zebrafish. We found that tlr2 mutation 
promoted Mm infection, affected macrophage functions and corresponded with 
reduced granuloma formation compared to the wildtype. In summary, we 
demonstrated that Tlr2 plays an important role in protecting the host during the early 
stage of mycobacterial infection. In addition, we performed RNA deep sequencing 
(RNAseq) and determined a Tlr2-specific gene list for the response to Mm infection. In 
particular, this revealed that most of the downregulation of genes caused by Mm 
infection in the control was abrogated by tlr2 mutation.  
 
Results 
1 tlr2 mutation prevents activation of tlr2-dependent genes in zebrafish larvae 
The tlr2sa19423 mutant (tlr2-/-) carries a thymine to adenine point mutation that creates a 
premature stop codon (Fig. 1A), which is located in the C-terminus of the leucine-rich 
repeat (LRR) domain. This leads to a truncated protein without the Toll/IL-1 receptor 
(TIR) domain, which is required for the interaction with Myd88 and Tirap (Mal) (36, 
37). 
    To confirm whether tlr2 mutation blocks its downstream pathway, we analyzed the 
gene expression profiles of zebrafish treated with the TLR2 agonist, Pam3CSK4. 
Pam3CSK4 was injected into the blood island of zebrafish embryos at 27 hpf. One hour 
after injection (hpi), we collected samples and performed qPCR to analyze the 
expression levels of TLR2-downstream effectors, CCAAT/enhancer-binding protein 
beta (cebpb) and FOS Like Antigen 1a (fosl1a), as we previously reported to be specific 
targets of Tlr2 signaling (35). In tlr2+/ sa19423 heterozygotes (tlr2+/-), the expressional 
levels of transcription factors cebpb and fosl1a, and inflammation marker gene il1b were 
significantly induced by Pam3CSK4, whereas tlr2-/- showed no significant response (Fig. 
1B). To confirm that these results are specific for the TLR2 pathway, we injected 






FIGURE 1 Characterization of the Tlr2 mutant. A, mutant DNA and protein sequence. A point 
mutation (T to A) in the C-terminal of the second LRR domain of zebrafish Tlr2 introduces a 
premature stop codon. The predicted truncated protein lacks the whole TIR domain. Nucleotide and 
amino acid positions are indicated with respect to the translation start codon. B and C, tlr2-/- and 
tlr2+/- embryos were injected at 27 hpf with 1 ng Pam3CSK4 or 0.1ng flagellin and expression levels of 
il1b, fosl1a and cebpb were determined at 1 hour post injection by qPCR. Data (mean ± SEM) are 
combined from at least three biological replicates (n=10 embryos per group) and expressed relative 
to their corresponding mock injection (water) control, which is set at 1. Statistical significance of 
differences between mock and Pam3CSK4 groups was determined by two-way ANOVA with Sidak 





analyses of GFP-labeled macrophages in 2dpf tlr2+/+/Tg(mpeg1:EGFP) and tlr2-/-/Tg(mpeg1:EGFP) 
embryos (at least 35 embryos per group) were performed based on stereo fluorescence images 
(green symbols indicate the data point for which representative examples are shown in figure S4). E, 
fluorescence relative pixel-count values of neutrophils derived from images of whole mount TSA 
immune staining (red symbols indicate the data point for which representative examples are shown 
in figure S4). Data (mean ± SD) are combined from two individual experiments. Statistical significance 
of differences was determined by T-test, **p<0.01, ns, no significant difference.  
 
inflammation marker il1b expression, but not cebpb and fosl1a expression in both tlr2+/- 
and tlr2-/- larvae (Fig. 1C). Overall, these data show that tlr2 mutation specifically 
blocks its downstream pathways.  
 
2 Macrophage and neutrophil phenotype in tlr2 mutant  
To study the effects of tlr2 mutation in immune cells, we conducted two individual 
experiments of TSA staining with 2dpf tlr2+/+/Tg(mpeg1:EGFP) and tlr2-/-Tg(mpeg1:EGFP) 
larvae. TSA staining detects Mpx activity, which is specific for neutrophils in zebrafish 
embryos and larvae. The combination of using mpeg1-EGFP fish lines and TSA staining 
can be used to distinguish macrophages (mpeg1:EGFP-positive, TSA-negative) and 
neutrophils (mpeg1:EGFP-negative, TSA-positive) (38). The numbers of macrophages 
in tlr2-/- larvae were significantly reduced compared to those in tlr2+/+ (Fig. 1D and Fig. 
S4) while the numbers of neutrophils was not significantly different between these 
groups (Fig. 1E and Fig. S4). We also conducted TSA staining in 2 dpf tlr2+/- and tlr2-/- 
larvae without the mpeg1:gfp marker, and confirmed that there was no significant 
reduction of neutrophils induced by tlr2 mutation Fig. S1). These results indicate that 
tlr2 mutation does not affect the development of neutrophils but may influence 
macrophage development. 
 
3 Mycobacterium marinum infection in tlr2 knockdown or mutant larvae 
We injected 28 hpf tlr2 morphants, standard control morphants, and tlr2-/- and tlr2+/- 
embryos with ~150 CFU Mma20 by blood island injection. The results of stereo 
fluorescence microscopy and pixel count analysis show that the bacterial burden in tlr2 
morphants was significantly higher than those of control larvae at 3 dpi (Fig. 2A). 
Considering the transient effect of morpholinos, we did not test later time points. In 
agreement, the bacterial burden was significantly higher in tlr2-/- than tlr2+/- larvae, 
with the most pronounced difference at 4dpi (Fig. 2B). Figure 2C represents the typical 







scanning microscopy (CLSM) confirming that tlr2 mutation promotes a higher 
bacterial burden during Mm infection. 
Protective immunity and latent Mm infection in zebrafish are associated with the 
formation of mature protective granulomas (39). In mice studies, Tlr2-deficiency 
resulted in a defective granulomatous response (18, 20). To test whether tlr2 mutation 
also suppresses the granuloma formation in zebrafish, we conducted CLSM imaging of 
tlr2-/-/Tg(mpeg1:EGFP) and tlr2+/+/Tg(mpeg1:EGFP) with Mma20 infection. We analyzed 
bacterial numbers and granuloma formation at several representative highly infected 
regions of zebrafish larvae at 4 dpi. We observed that tlr2+/+ larvae showed normal 
granuloma formation and the majority of the bacteria was inside macrophages.(Fig. 
3A-D). In contrast, in two representative locations in tlr2-/- larvae (Fig. 3E), a majority 
of the bacteria congested together and formed a big cluster without evidence for being  
FIGURE 2 Quantification of bacterial burden. 
tlr2 morphants (A) or tlr2+/- and tlr2-/- embryos 
(B) were infected at 28 hpf with ~150 CFU 
Mma20 strain. Stereo fluorescence images of 
Mma20 infected embryos at 3 and 4 days post 
injection were used for quantification of 
bacterial fluorescence pixels. Data (mean ± SD) 
are combined from three individual 
experiments. Statistical significance of 
differences was determined by T-test (A) and 
one-way ANOVA with Tukey’s Multiple 
Comparison method as a post-hoc test (B). 
**p<0,01. C, tlr2+/- and tlr2-/- embryos were 






FIGURE 3 Granuloma formation and macrophage phenotypes in the Tlr2 mutant upon Mma20 
infection. The tlr2+/+/Tg(mpeg1:EGFP) (A-D) and tlr2-/-/Tg(mpeg1:EGFP) (E-H) embryos were infected 
at 28 hpf with ~150CFU Mma20 strain. Confocal laser scanning imaging was conducted using a Leica 
SP1 microscope with 10 (A, E) and 63 (B-D and F-H) times magnification lenses. GFP-green, 
macrophage; mCherry-red, Mma20; white arrow head indicates the enlarged section of this picture. 
The size bar in bright view figure A represents 50um, in fluorescence view figure D represents 10um. 
(B-D and F-H) enlargements of the areas indicated in panels A and E. The positions indicated by 
arrowheads are the reference points. In the Tlr2 mutant they point to clusters of bacteria that are 
not present inside macrophages. In the control they point to macrophages that have ingested 
bacteria, which are observed much more frequently than in the mutant. The images are 






inside macrophages. (Fig. 3E-H). Furthermore, these results show that the tlr2-/- 
mutant allows higher Mm proliferation and is impaired in granuloma formation 
compared to the tlr2+/+ control.  
To further quantify the migration of macrophages after Mm infection, we performed 
cell tracking to measure the maximum migration distance from the start of the image 
sequence and their average speed from 84 to 96 hpi (Fig. 4). In this study, the location 
of the bacteria-containing macrophages in the first frame of the movie was set as the 
origin and we then tracked the migration of the macrophages during the following 
twelve hours. Our results show that both the maximum distance of migration and the 
average speed of macrophage migration in tlr2-/- was significantly higher than that in 
tlr2+/+ (Fig. 4C and D). These results show that tlr2 mutation affects macrophage 
migration after infection.  
 
4 Tlr2-specific gene expression profiles after Mycobacterium marinum infection 
To assess the general inflammation and specific immune responses in tlr2 mutants, we 
studied mRNA expression levels of il1b, tnfa, tnfb, irg1l , and tlr2 specific transcription 
factors fosl1a and cebpb in tlr2-/- and tlr2+/- larvae upon Mma20 infection by qPCR at 
4dpi. Our results show that the expression levels of il1b and tnf in tlr2-/- larvae are 
significant reduced (Fig. 5A-C). The induction of cebpb and fosl1a was inhibited in tlr2-
/- larvae (Fig. 5E, F). The expression of irg1l showed no significant difference between 
infection and non-infection in the tlr2-/- larvae (Fig. 5D). In previous work from our 
laboratory, Cxcl11-like chemokines were shown to play a crucial role in macrophage-
mediated granuloma formation upon Mm infection (40). We therefore conducted 
qPCR to characterize the expression level of cxcl11-like genes, previously shown to be 
infection inducible (40), including cxcl11aa and cxcl11ac (Fig.5G and H). The expression 
level of gene cxcl11aa and cxcl11ac was significantly higher in tlr2+/- larvae than in tlr2-/-
 upon Mm infection (Fig. 5G, H). These results indicate that tlr2 mutation results in a 







FIGURE 4 Cell tracking of macrophages in (A) tlr2+/+/Tg(mpeg1:EGFP) and tlr2-/-/Tg(mpeg1: EGFP) (B) 
larvae with Mm infection. Embryos were infected with ~150 CFU Mma20 strain at 28hpf, imaging 
was performed using a Nikon Eclipse Ti-E inverted microscope (40×) from 84hpi to 96hpi. There are 
46 frames from tlr2+/+ (A, bottom panel) and 70 from tlr2-/- (B, bottom-panel) that were analyzed, 
resulting in the reconstruction of 23 macrophage tracks in the wildtype and 12 in the mutant. The 
upper-panel in A and B shows the track of macrophages in 2D view, the insets are the original 
representative images and the bottom-panel shows that in 3D view. C and D, the maximum 
migration distance from the original site of infection in the first frame of the movie and the average 
speed of macrophages after phagocytosis of bacteria. The statistical significance of differences was 







FIGURE 5 Immune genes expression in tlr2+/- and tlr2-/- fish lines infected with Mm. The expression 
levels of il1b (A), tnfa (B), tnfb (C), irg1l (D), fosl1a (E), cebpb (F), cxcl11aa (G) and cxcl11ac (H) were 





(n = 10 embryos per group) and expressed relative to their corresponding mock injection (PBS) 
control, which is set at 1. Statistical significance of differences was determined by two-way ANOVA 
with Sidak Multiple Comparison test as a post-hoc test. *p<0.05, **p<0.01, ****p<0.0001  
 
To further study the function of tlr2 in defense against mycobacterial infection, we 
performed RNAseq of tlr2+/- and tlr2-/- larvae infected with 150 CFU Mma20 at 4dpi and 
PBS-injected controls. We summarized the number of differentially expressed genes 
(DEGs) according to p-value (Fig. 6A, B). tlr2+/- induced an increased number of DEGs 
than tlr2-/- with Mma20 infection at any given p-value or false discovery rate less than 
0.05, or any given fold-change with a p-value less than 0.05. The data also shows that 
most of the downregulation of genes caused by Mm infection in the control was 
abrogated by tlr2 mutation (Fig. 6A, B). To further analyze these RNAseq data, we 
chose the genes with a threshold of a p-value less than 0.05 in tlr2+/- with Mma20 
infection (1102 up- and 827 down-regulated genes, Fig. 6A). Then, for these 1102 and 
827 genes, we calculated the ratio of the fold-change of tlr2+/- versus tlr2-/-, after that, 
the genes with ratio greater than 2 or less than 0.5 were screened (Fig. 6C). As a result, 
97 and 92 genes were selected as tlr2 specific up- and down-regulated genes, 
respectively. We conducted gene ontology (GO) analysis (Fig. 6D, E) showing that 
genes that grouped into the immune system category are the most prominently 
deregulated (36%) in the whole tlr2 up-regulated 97-gene set (Fig. 6D). Within this 
category we found genes involved in lysosome, chemotaxis, transcription regulation, 
diverse immunoglobulin domain-containing proteins (dicps) and other immune 
processes (Fig. 6D and 7A-E). For other process related categories, many up-regulated 
genes fell in the categories oxidation-reduction process, DNA repair, transcription 
regulation and apoptotic process regulation (Fig. S2). In the tlr2 down-regulated 92-
gene set, the immune related genes also were the largest portion (15%; Fig. 6E, 7F). The 
categories of non-immune related genes are listed in Fig. S3. Our results show that tlr2 
mutation leads to far less immune response genes that are upregulated upon Mm 
infection in zebrafish larvae.  
To show the relationship between the genes that are differentially expressed, we 
constructed networks based on common expression targets in the 97 up- and 92 down-
regulated genes (41). The involved networks with the up-regulated genes contain LIPC, 
NR0B2, HMGCR, ITLN1, FGF23, VDR, IRAK3 and TLR8 (Fig. S5). In the tlr2+/- control 
we observed positively regulated HMGCR, FGF23, VDR and TLR8, and negatively 
regulated NR0B2, whereas tlr2-/- shows an opposite regulation for most of them. 
However, LIPC and IRAK3, were positively regulated in both tlr2+/- and tlr2-/-. For the 
92 downregulated genes, a network containing NROB2 and MAFB was constructed 
(Fig. S6). NR0B2 and MAFB were positively regulated in tlr2-/- zebrafish and down 











FIGURE 6 Overview of RNAseq results. A, B the number of DEGs of tlr2+/- and tlr2-/- strains infected 
with Mm compared to the control at different p-value and fold change. C, the work flow of screening 
genes of which the regulation by infection is dependent on tlr2. D, GO analysis of the 97 upregulated 
genes. E, GO analysis of the 92 down-regulated genes. FC, fold-change. F, the DEGs number of tlr2-/- 
versus tlr2+/- at different FDR p-value in the uninfected mock-injected condition. 
 
5 Enrichment analysis of Tlr2 specific genes after Mycobacterium marinum infection 
To link our data to gene sets defined based on prior biological knowledge (including 
GO), we conducted Gene-Set Enrichment Analysis (GSEA) of the genes of which the 
ratios of Mm infection and control in tlr2+/- or tlr2-/- zebrafish are significantly different 
without considering fold-changes. This method derives its power by focusing on gene 
sets, that is, groups of genes that share common biological function, chromosomal 
location, or regulation (42). Because the numbers of predicted gene sets were too large 
for our analysis method (more than 1,000 with p < 0.05), we focused on the gene sets 
related to metabolic, immunological and inflammation pathways. The GSEA predicted 
61 pathways in tlr2+/- and 67 pathways in tlr2-/- zebrafish responsive to Mma20 
infection (Supplementary Table 2A and 2B). Interestingly, most of these pathways are 
common in tlr2+/- and tlr2-/-, however some of them are detected as being anti-
correlated in regulation, including some pathways underlying natural killer cell 
functions and omega-6-fatty acid metabolism (Supplementary Table 2C). We also 
performed Sub-Network Enrichment Analysis (SNEA) (43) to identify possible key 
genes that are responsible for the difference in response of the tlr2+/- and tlr2-/- group 
to Mm infection (p < 0.05). SNEA predicted 565 and 503 pathways for tlr2+/- and tlr2-/- 
zebrafish that are linked to the response to infection, respectively (Supplementary 
Table 2D and 2E), and 264 and 202 of them are specific for the response in tlr2+/- and 
tlr2-/- fish, respectively (Supplementary Table 2F). Since the RNAseq was conducted 
with the total RNA from whole body of zebrafish, it is not possible to define which 
pathways are involved in macrophage functions related to tlr2 expression. Therefore, 
we downloaded DNA microarray data (GDS4781) of human macrophages transfected 
with M.tuberculosis from Gene Expression Omnibus (44). SNEA analysis of human 
macrophages shows that 659 pathways are linked to Mtb infection (Supplementary 
Table 2G). By comparing human SNEA result to tlr2+/- specific pathways in zebrafish, 
56 pathways were defined as tlr2+/--specific (Supplementary Table 2H). Of these, the 
pathway of TLR8, which has the lowest p-value in both zebrafish and human 
enrichment, and its network is depicted as example in Figure S7. In general these 
analysis show that the tlr2-/- mutant has a very different immune response of which 











FIGURE 7 Overview of fold changes of representative genes selected from the gene categories 
resulting from GO-term analysis. A-E: tlr2-dependent genes with upregulation corresponding to Fig. 
6D. F: tlr2 specific genes with downregulation corresponding to Fig. 6E.  
 
6 Comparison of gene expression profiles of tlr2 homozygote mutant with heterozygote 
We compared basal levels of gene expression in the absence of infection between tlr2 
homozygote and heterozygote mutants. These results show that there is a large group 
of genes that are expressed differently even at extremely stringent p-values (Fig. 6F). 
To get possible indications whether the basal expression level differences of genes 
might be relevant to the Tlr2 pathway we performed GO analysis of a set of genes that 
were expressed differently with the very low FDR p-value of 10-10 (Supplementary Table 
3). Our results show that there is a large enrichment of genes belonging to the GO 
terms related to neural development. In addition, we have also analyzed differences 
with a fold change criterion of two and FDR p-value of 0.05 (Supplementary Table 4). 
These analyses indicated that under the GO category transcription factor genes only 
two categories of genes including the c-Maf transcription factor (Supplementary Table 
4) were present. Finally, the RNAseq analysis showed that the mpeg1.1 gene is 
expressed approximately 2 fold higher in the tlr2+/- control than in the tlr2-/- mutant 
(Supplementary Table 5), consistent with the observation of reduced macrophage 
numbers in the tlr2 mutant (Fig. 1D, Fig. S4). 
 
Discussion 
Our study created a systemic tlr2 deficiency-Mm infection model in zebrafish larvae to 
study Tlr2 function in the innate immune system during mycobacterial infection. In 
alternative model systems for human tuberculosis that use mice, it is difficult to 
perform systemic studies at the genomic and microscopic level. As a result all the 
studies performed in mice have been carried out with isolated tissues. Furthermore, 
there are only a few RNA sequencing results of TB studies in rodents (45, 46), human 
serum (47), human pulmonary epithelial cells (48), and bovine systems (49-52). In 
zebrafish larvae it is possible to combine the advantage of studying the entire system 
using transcriptomics and zooming in on mechanisms of the infection process using 
fluorescence microscopy. Furthermore, as in rodents, the zebrafish offers excellent 
genetics tools for obtaining mutants such as the tlr2 mutant described in this study. 
The deep sequencing data provided the chance to study the whole transcriptome 
profile in our mycobacterial infection model and revealed the panorama of tlr2 





were able to document in vivo the impact that lack of Tlr2 has in the interaction 
between infecting bacteria and macrophages. 
We have shown in this study that tlr2 mutant leads to increased mycobacterial 
infection in zebrafish larvae. This result is similar to results from studies in Tlr2 
knockout mice, where infection with Mtb resulted in increased lung infection and 
highly increased mortality (19, 20). However, in these works a role of Tlr2 could only be 
shown at high doses of infection, whereas at a low dose no effect was observed of the 
mutation (19,20). In the study of Drennan et al (20) it was shown that infection of the 
Tlr2 mutant leads to a decrease of the number of granulomas formed in the lungs. This 
is in line with our results where we found that the clustering of macrophages in pre-
granuloma structures was strongly decreased. In addition, the study in mice showed 
that in the Tlr2 mutant there was an increased T cell response that was ineffective in 
combating progression of infection. Since in our larval system there is no adaptive 
response present, we can therefore not address this point and need to perform studies 
in adults in future studies. However, it is important that we can conclude that the role 
of Tlr2 in granuloma formation is not dependent on T cell activity. Furthermore, we 
can now also conclude that the function of Tlr2 in granuloma formation is at the very 
early steps of the infection process. We also observed that Tlr2 mutants in zebrafish 
larvae result in a decreased number of macrophages even in the absence of infection 
and this might attributed to the emergence and differentiation of hematopoietic stem 
and progenitor cells. He et al. (53) demonstrated that Tlr signaling-dependent 
inflammatory signaling is necessary and sufficient for hematopoietic stem and 
progenitor cells emergence in zebrafish, in the absence of infection or pathological 
inflammation. TLR2 agonist Pam3CSK4 was also shown to induce a large proportion of 
hematopoietic stem cells to express markers of the myelomonocytic lineage (54). On 
the other hand, Herman et al. (55) showed that systemic exposure of mice to a TLR2 
agonist leads to an expansion of bone marrow and spleen phenotypic hematopoietic 
stem cells and progenitors, but a loss of hematopoietic stem cell self-renewal capacity. 
We also observed that the Tlr2 mutation in zebrafish larvae induces an increased speed 
and the maximal distance of macrophage migration in the presence of infection (Fig. 
4). These results might indicate that macrophages in the mutant might be less 
differentiated than those in the wildtype. These factors could contribute to the 
proliferation of infection.  
Since the molecular mechanisms that underlie the role of TLR2 in the control of 
infection are still unknown we have performed RNAseq of entire larvae with our 
infection system. We also analyzed the basic expression levels of the mutant versus the 
control and noted a strong difference of the expression of a large group of genes in the 
absence of infection. Since little is known about the variations in basal gene expression 
levels in larvae from different crosses it is hard to speculate whether these differences 





undoubtedly differences in development of individual larvae that are not filtered away 
by pooling and that will provide differences in organ development and metabolism 
that will lead to large variations in gene expression levels. In addition, also differences 
in the genetic makeup of the parents used for obtaining the batches of larvae are 
unknown and therefore it will not be possible to obtain solid conclusions. However, 
the largest category of genes that was significantly affected, namely neurological 
system process, might still be linked with a function of Tlr2. Many recent studies show 
that a mutation in Tlr2 in mice resulted in effects of neuronal development and 
responses to injury (56, 57). Some of these studies show a connection of Tlr2 in 
neuronal defects to be related to IL10 and possibly autophagy (58, 59). When focusing 
on the possible signaling pathways that could be involved we observed that there was a 
significant effects in the GO category of transcriptions factor, namely the c-Maf factors 
that totals up to 546 representatives that were affected (Supplementary Table 4). As 
members of Maf family transcription factors, c-Maf and Mafb are specifically expressed 
in monocyte and macrophage lineages (60, 61), in addition, c-Maf is also expressed in T 
helper cells (61). c-Maf was also reported to directly regulate IL-10 expression induced 
by LPS in macrophages (62). Double deficiency of Mafb/c-Maf promotes self-renewal 
of differentiated macrophages (63), which might indicate a link to the effect of the Tlr2 
mutation on the number of macrophages in the absence of infection.  
An analysis of the difference of induction and repression of genes during infection 
showed that that is a very pronounced effect of mutation of the Tlr2 gene. With 
respect to the number of genes affected, The strongest effect was observed on the 
genes that are down regulated during infection, since this category was strongly 
affected in the Tlr2 mutant (Fig. 6A, B). This category of genes includes several genes 
that are related to innate immune response and also many unknown genes. This 
indicates that Tlr2 has an important function in anti-inflammatory responses. This is in 
line with previous reports of studies in mice that showed a strongly decreased anti-
inflammatory response in Tlr2 knockouts (64, 65). In a further analysis on the 
quantitative effects on the differences in expression levels of the genes that are affected 
in both the up regulated as down regulated groups we selected a group of genes that 
were most significantly affected for Gene Ontology analysis (Fig. 6D, E). This GO 
analysis showed many groups to be affected with the immune response as the biggest 
group. We also performed GSEA and SNEA analyses showing that the tlr2-/- mutant 
has a very different immune response than the heterozygote control line and that 
many signaling pathways that are linked to responses to human tuberculosis infection 
are differently responding. Most significantly, activation of the Tlr8 pathway was 
strongly affected (Fig. S7). This suggests that the Tlr2 signaling is strongly connected 
with Tlr8 function. TLR8 mutations (polymorphisms) increase susceptibility to 
mycobacteria (66, 67). These predictions from integrated transcriptome analysis are 





known immune genes we want to discuss three other very interesting categories of 
genes. 
The vitamin D receptor pathway genes that are normally up-regulated during 
infection in zebrafish larvae were down regulated in the Tlr2 mutant. Furthermore, 
pathway analysis (Fig. S5 and S7) also implicated the expression of the Tlr8 pathway 
connected to vitamin D signaling as being strongly affected in the Tlr2 mutant. 
Vitamin D has been shown to be an important regulatory factor during tuberculosis 
(68) and has been linked previously to TLR2 function in studies in cell cultures (69).  
Tlr2 showed to be essential for the up-regulation of a group of genes that encode the 
Diverse Immunoglobulin Domain-Containing Proteins (DICPS). This group is as novel 
multigene family encoding diversified immune receptors. Haire et al (70) reported that 
recombinant DICP Ig domains bind lipids and lipid extracts of different bacteria, 
including Mtb and Mm, a property shared by mammalian CD300 and TREM family 
members. In the down-regulated set also several DICP proteins appear to be 
dependent on Tlr2, such as dicp1.17, dicp3.3, that are linked to the GO term insulin-like 
growth factor binding. These correlations might relate to functions of TLR2 in other 
processes such as the control of diabetes type II by gut microbiota. However, the DICP 
gene family lacks easily recognizable genetic orthologues in mammals, making a 
translation to a function in mammalian tuberculosis and other diseases currently not 
yet possible (71).  
Another highly relevant large category of genes of which the induction or repression 
during infection is dependent on Tlr2 includes the chemokines. In a previous study of 
our laboratory, Torraca et al. (40) demonstrated the function of the CXCR3-CXCL11 
axis in macrophage recruitment and showed that disruption of this axis by cxcr3.2-
mutation increases the resistance to mycobacterial infection. They also showed that 
Cxcr3.2 deficiency limited the macrophage-mediated dissemination of mycobacteria 
and attenuated the formation of granulomatous lesions and led to a reduction in the 
total bacterial burden (40). In our study, the tlr2 mutant shows a significantly lower 
expression of cxcl11aa and cxcl11ac during Mm infection (Fig. 5). Considering the large 
number of other chemokines that are controlled by Tlr2 during infection, it is clear 
that the integrative network of connections cannot yet be understood from these 
expression studies and need more detailed functional analyses, e.g. by combinations of 
different mutations or directed studies on responses to chemokines as shown by 
Torraca et al. However, we can state that the phenotypes of the tlr2 mutant, at the 
microscopic level, and the level of transcriptional control such as the mentioned 
effects on regulation of MafB/c-Maf and chemokines shows a clear connection with 
macrophage migration. This does not exclude that Tlr2 has many other functions in 
macrophage behavior during infection such as phagocytosis. For instance, Blander et al. 





maturation are impaired in the absence of TLR signaling. Therefore, the large number 
of unannotated genes of which the expression during infection is dependent on Tlr2 is 
also worth studying in more detail in future studies. 
In conclusion, our study shows that TLR2, as a part of innate immunity, plays an 
important role in controlling mycobacterial infection as observed on the transcriptome 
and infection level. This may be mediated by several strategies, including macrophage 
migration and clustering, and other anti-mycobacterial effect like vitamin D signaling. 
The anti-inflammatory function of TLR2 as indicated by our study could be mediated 
by IL10. The gene il10 is also controlled by other bacteria, yeasts or viruses to mediate 
immune evasion through TLR2 and therefore seems to have an opposing function as to 
what we report for mycobacterial infection (25, 26, 74). The TLR2 mutant is therefore 
highly suitable for further studies using the published infection models for other 
microbes and viruses in zebrafish larvae. This will make it possible to compare the 
possibly different roles of TLR2 in interactions with various microbes in one infection 
model.  
 
Materials and methods 
Zebrafish husbandry  
The tlr2sa19423 mutant line (ENU-mutagenized) was obtained from the Sanger Institute 
Zebrafish Mutation Resource (Hinxton, Cambridge, UK) and shipped by the zebrafish 
resource Center of the Karlsruhe Institute of Technology. The mutant allele was 
identified by sequencing. Heterozygous carriers of the mutation were outcrossed twice 
against wildtype (AB strain), and were subsequently incrossed twice. Heterozygous fish 
of the resulting family were used to produce embryos. Homozygous mutants were 
outcrossed to the Tg(mpeg1:EGFP)gl22 transgenic line, and the offspring with GFP 
florescence were subsequently incrossed to produce tlr2-/- / Tg(mpeg1:EGFP) line. 
    All zebrafish were handled in compliance with the local animal welfare regulations 
and maintained according to standard protocols (zfin.org). Larvae were raised in egg 
water (60 g/ml Instant Ocean sea salts) at 28.5 °C. For the duration of bacterial 
injections, larvae were kept under anesthesia in egg water containing 0.02% buffered 3-
aminobenzoic acid ethyl ester (Tricaine, Sigma-Aldrich, the Netherlands). The culture 
of zebrafish with mutations in immune genes was approved by the local animal welfare 
committee (DEC) of the University of Leiden (protocol 14198). All protocols adhered to 
the international guidelines specified by the EU Animal Protection Directive 
2010/63/EU.  





The bacterial strain, Mycobacterium marinum m20 (Mma20) expressing mCherry 
fluorescent protein (75), was used in this study. For the infection to zebrafish larvae, 
the bacteria were prepared as previously described (76). The infection inoculum was 
prepared in 2% polyvinylpyrrolidone40 solution (CalBiochem, the Netherlands), and 
150 colony-forming units (CFU) of bacteria were injected into the blood stream at 28 
hours post fertilization (hpf) as previously described (77).  
Ligands injection 
Purified Pam3CSK4 (InvivoGen, France) and flagellin from S. typhimurium (Flagellin 
FliC VacciGrade™, Invitrogen, France) were diluted in 1 mg/ml and 100 μg/ml in sterile 
water, respectively. For injection, 1 nl of the ligand solutions were injected into the 
blood stream at 28hpf. Sterile water was injected as a control experiment. Injections 
were performed using a FemtoJet microinjector (Eppendorf, the Netherlands) 
equipped with a capillary glass needle.  
Morpholino injection 
Morpholino oligonucleotides (Gene Tools, Philomath, US) were diluted to desired 
concentrations in 1× Danieau’s buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 
mM Ca(NO3)2, 5.0 mM HEPES[pH 7.6]) containing 1× phenol red (Sigma-Aldrich, the 
Netherlands). For knockdown experiments, tlr2 ATG-morpholino (tlr2 mo, 5'- 
AGTCATTG TTCCTACGAGTCTCATC-3') was injected with the optimal concentration 
at 0.5mM and 1nl volume per embryo at 1-2 cell stages. Control larvae were injected 
with the standard control morpholino (Ctrl mo, 5'-CCTCTTACCTCAGTTACAATTTA 
TA-3').  
Immunohistochemistry 
Larvae were fixed in 4% paraformaldehyde in PBS overnight at 4°C. Myeloperoxidase 
(Mpx) activity was labeled using TSA-Plus Systems (Perkin Elmer, Waltham, MA, US) 
as previously described (78).  
Imaging and quantification of bacterial loads  
Pools of 20 larvae were collected at 3- and 4-day post infection (dpi) and imaged by 
using the Leica MZ16FA Fluorescence Stereo Microscope (Leica Microsystems, info) 
equipped with the Leica DC500 camera (Leica Microsystems). Bacterial loads were 
analyzed using dedicated pixel counting software as previously described (79). 
Experiments were performed in triplicate.  
Confocal microscopy imaging 
Larvae (4 or 5 dpf) were embedded in 1% low melting point agarose (Sigma Aldrich), 





(Leica Microsystems) or a Zeiss LSM exciter on an Axio Observer confocal microscope 
(info) with 10 or 63 times objectives. Acquisition settings and area of imaging (in the 
caudal vein region) were kept the same across the groups for quantification of the 
bacterial burden.  
Macrophage tracking 
To visualize the granuloma formation and the leukocyte phenotype, tlr2-/- zebrafish 
were crossed with macrophage-specific reporter line Tg(mpeg1:EGFP), leading to 
tlr2+/+/Tg(mpeg1:EGFP) and tlr2-/-Tg(mpeg1:EGFP) fish lines. tlr2+/+ and tlr2-/- -
Tg(mpeg1:EGFP) embryos were injected with 150 CFU Mma20 at 1dpf. They were 
anesthetized and mounted in 1% low-melting agarose and subsequently imaged using a 
Nikon Eclipse Ti-E inverted microscope (40×) as described previously (80) from 84 hpi 
to 96 hpi. Images were taken every 6.5 min, extracted, and converted to movies using 
NIS-Elements AR software. ImageJ (NIH, Bethesda, ML, USA) was used to align all the 
frames. CellTracker (ver. 1.1, Copyright (©) 2015 Peter Horvath and Filippo Piccinini) 
was employed to analyze the moving tracks of infected macrophages. 
RNA isolation, cDNA synthesis and qPCR 
Total RNAs were extracted using TRIzol Reagent (Life Technologies) and purified 
using RNeasy MinElute Cleanup Kit (Qiagen, the Netherlands). The concentration and 
quality of RNAs were evaluated by NanoDrop 2000 (Thermo Scientific, the 
Netherlands). cDNAs were synthesized from 1 μg total RNAs and qPCR were 
performed by using the iScript™ cDNA Synthesis Kit (BioRad, the Netherlands) and 
iQ™ SYBR Green Supermix (BioRad) and normalized against the expression of ppial as 
a housekeeping gene (81). Results were analyzed using the ΔΔCt method (82). Primer 
sequences are described in Supplementary Table 1.  
Deep sequencing and data analysis  
Triplicates of 10 larvae of tlr2+/- and tlr2-/- with PBS (as control) or Mma20 injection, 
were homogenized in 300ul of TRIzol reagent, and total RNAs were purified as 
described above. RNAseq was performed using Illumina Hi-Seq 2500 as previously 
described (83). The RNAseq data were mapped on zebrafish genome (GRCz10 version) 
and tag counts were performed by Bowtie 2 using GeneTiles software (http://www. 
genetiles. com) (84, 85). Then, we performed normalization and gene expression 
analysis using the R package and DESeq2 (86). After statistical tests, we performed 
further bioinformatics analyses Gene-Set Enrichment Analysis (42), Sub-Network 
Enrichment Analysis (43) and Pathway Enrichment Analysis (87). For creating gene 
networks based on common regulatory targets, we used Pathway Studio 9.0 (Elsevier, 
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Supplementary figure 1 Relative pixel count analysis for TSA staining of neutrophils in 2dpf 
tlr2+/- and tlr2-/- embryos. 
 















Supplementary figure 4 Representative images of Fig. 1D and 1E. Green signal represents 
macrophages, red signal represents neutrophils. 
 
 
Supplementary figure 5 Sub-network enrichment analysis. The networks of common targets 
of the 97 up regulated genes (Fig.6D) in tlr2+/- (A) and tlr2-/- (B) with Mma20 infection. Red 
represents up regulation, blue represents down regulation and grey represents genes for 















Supplementary figure 6 Sub-network enrichment analysis. The networks of the common 
targets of the 92 down regulated genes (Fig. 6E) in tlr2+/- (A) and tlr2-/- (B) with Mma20 
infection. Red represents up-regulation, blue represents down-regulation and grey 







Supplementary figure 7 Sub-network enrichment analysis between zebrafish and human. 
The Tlr8 pathway in zebrafish (A) with Mm infection and human macrophages (B) with Mtb 








Supplementary Table 1 List of primers 
Supplementary Table 2 A-H Gene lists of GSEA and SNEA analysis 
Supplementary Table 3 GO analysis of genes that have a different basal expression level in 
the absence of infection in the Tlr2 mutant versus the heterozygote control. Shown is the GO 
analysis of the group of 878 genes that were different with a FDR p value of 10-10 indicated in 
Fig. 6F.  
Supplementary Table 4 List of transcription factors under GO category in absence of 
infection 
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The Traf6 and Ikk2 proteins are partners in the signal transduction pathway 
underlying innate immunity and are involved in multiple pathological processes. 
Furthermore, they are also important for development, as shown by the fact that the 
total deficiency of Traf6 or Ikk2 in rodents is lethal. We analyzed zebrafish Traf6 and 
Ikk2 mutants with a stop codon in the reading frame of the protein coding sequences 
(traf6sa244/sa244 and ikk2m10/m10 ). We characterized the influences of these traf6 and ikk2 
mutations on immunity and development. In the case of ikk2 we also tested the 
response to hyperinsulinemia, since Ikk2 has previously been implicated in insulin 
signaling. Both mutants did not show any visible abnormal organ phenotype during 
embryonic or later developmental stages, and the adults were also capable of breeding. 
There were no consistent indications for effects on leukocyte phenotype in 
traf6sa244/sa244. In contrast, ikk2m10/m10 larvae showed a significant decrease in body size, 
leukocyte numbers and expression of marker genes for macrophages and neutrophils. 
For analysis of immune responses we infected the mutants with Mycobacterium 
marinum and measured bacterial proliferation. In the case of the traf6 mutant no 
significant difference with the wildtype in susceptibility to infection could be observed 
and the surprising lack of phenotypes of this mutant is discussed. The ikk2m10/m10 larvae 
showed a higher bacterial burden than ikk2+/+ larvae upon M. marinum infection. In 
addition, in the ikk2 mutant the insulin resistance induced by hyperinsulinemia was 
modulated. We also studied the inflammatory response induced by flagellin in the ikk2 
mutant through activating Tlr5 signaling. Unexpectedly, we found that in the ikk2 
mutant a significantly higher expression of il1b was induced than in the control. This 
result might be attributed to the overexpression of ikk1 in the ikk2 mutant, which 
perhaps plays a compensatory role in il1b expression induced by flagellin. Considering 
the phenotype of the ikk2 mutant in both infection and insulin resistance this mutant 
provides new possibilities to further study the connection of innate immunity and 
metabolic diseases.  
 
Introduction 
Toll like receptors (TLRs) are an important class of pattern recognition receptors 
(PRRs). TLRs recognize conserved pathogen-associated molecular patterns (PAMPs) 
from microbial components and danger-associated molecular patterns (DAMPs) from 
the host itself. Thereby they initiate signaling pathways by the activation of NF-κB or 
AP-1 transcription factors and finally activate inflammatory and immune responses. 
Tumor necrosis factor receptor associated factor 6 (TRAF6), plays a critical role in 
mediating these processes. After signal transduction is initiated from the Toll/IL-1R 





receptor complex. Subsequently, TRAF6 dissociates from this receptor complex, and 
associates with TAK1, TAB1 and TAB2 to form a new complex. This new complex then 
translocates from the plasma membrane to the cytosol and is ubiquitinated by 
ubiquitin ligases UBC13 and UEV1A. Finally, it actives the MAPKs and the IKK complex 
(IKK1, IKK2 and NEMO), resulting in AP-1 and NF-κB activation (1, 2). In addition to 
functioning in the TLR/IL-1R signal transduction pathway, TRAF6 also interacts 
directly with TGFβRI/ALK5 (3, 4) and proteins from the TNF-receptor family, such as 
CD40 and TRANCER, also known as RANK (1, 5), that in turn activate the PI3K and 
downstream Akt/PKB pathway. 
In mammals TRAF6 is broadly expressed in various tissues and cells, but most 
immune cells restrict their activity through selective expression of receptors used to 
activate TRAF6 (6). Moreover, TRAF6 has been shown to be critical for developmental 
processes (7, 8), bone metabolism (9) homeostasis (10), apoptosis (11) and cancer (12, 
13). For instance, Traf6 knockout mice showed a high mortality within three weeks 
after birth, accompanied by severe defects in the encephalon and neural tube and 
abnormal regulation of the central nervous system (9, 14, 15). It has also been 
demonstrated that TRAF6 is important for the immune system, since Traf6-deficient 
chimeras generated a progressive lethal inflammatory disease associated with massive 
organ infiltration and a dominant Th2-type polarized autoimmune response (16). 
TRAF6 regulates the critical processes required for maturation, activation, and 
development of dendritic cells (DCs) (14). Mice that are deficient for Traf6 specifically 
in their regulatory T cells, developed allergic skin diseases, arthritis, lymphadenopathy 
and hyper IgE phenotypes (17). Furthermore, TRAF6 is a key component in the 
signaling cascade downstream of C-type lectin receptors and is a critical mediator of 
the anti-fungal immune response (18). TRAF6 is also required for production of IL-12 in 
control of parasite infections (19).  
In the canonical NF-κB signaling, the IKK complex is activated by the 
TRAF6/TAK1/TAB1/ TAB2 complex. As the key catalytic subunit in the IKK complex, 
IKK2, also named as IKKβ or IKBKB, is essential for NF-κB activation in response to 
pro-inflammatory stimuli. Knockout of Ikk2 is lethal in mice (20, 21), but conditional 
knockout of Ikk2 can even reverse some pathological diseases and lesions induced by 
the IKK2/NF-κB signaling pathway. For instance, Ikk2 conditional knockout or 
inhibition in mice attenuates laser-induced choroidal neovascularization, a leading 
cause of blindness in the elderly (22), and reduces liver necrosis and inflammation 
from ischemia/reperfusion injury (23). However, mice with epidermis-specific deletion 
of Ikk2 develop a severe TNF-mediated inflammatory skin disease (24). Furthermore, 
Ikk2 has also been shown to be required for a proper response to infection in mice (25-
28). For instance, previous studies indicate that selective ablation of lung epithelial 
Ikk2 impairs pulmonary Th17 responses and delays the clearance of Pneumocystis, an 





immunocompromised patients (25). The pharmacological inhibition of IKK2 prevents 
human cytomegalovirus replication and virus-induced inflammatory response in 
infected endothelial cells (26). Interestingly, Ikk2 has also been implicated in insulin 
sensing, where heterozygous deletion of Ikk2 protected against the development of 
insulin resistance during high-fat feeding in obese ob/ob mutant mice (29). Moreover, 
inactivation of Ikk2 prevents insulin resistance in skeletal muscle by blocking fat-
induced defects in insulin signaling (30).  
Zebrafish has become an important vertebrate model for studying human diseases, 
such as cancer (31, 32), tuberculosis (33, 34), microbial infections (35, 36), 
neurodegeneration (37, 38), and developmental and metabolic diseases (39, 40). Their 
small size, transparent larvae and short generation time of 3-4 months are beneficial 
for the screening and imaging of transgenic lines. The excellent imaging tools and 
applicability of microinjection of disease inducing agents allow the study of the 
function of Traf6 and Ikk2 in different disease models in zebrafish. TRAF6 shows a 
highly conserved structure from mammals to zebrafish (5, 41, 42). In a previous study 
from our laboratory it was shown that Traf6 has a dynamic role as a positive and 
negative regulator in a zebrafish-Salmonella infection model, based on transcriptome 
profiling by a combination of microarray analysis and whole transcriptome deep 
sequencing of Traf6 morphants (43). 
In this study, to further analyze the role of Traf6 and Ikk2 upon Mycobacterium 
marinum (Mm) infection, we conducted infection experiments using traf6 and ikk2 
mutant zebrafish. We found that the traf6 mutant display an absence of phenotypes 
that was not expected from results of previous studies. Specifically, we could not 
demonstrate an effect of the mutation in the defense of larvae to mycobacterial 
infection. Since we are not able to show any specific phenotype resulting from the 
mutation in Traf6 we consider it likely that it does not represent a null mutant, 
perhaps because of residual activity of a truncated protein or of the result of 
suppression by other mutations. In contrast, the ikk2 mutant shows higher bacterial 
burden than wildtype upon infection with Mm. Furthermore, the ikk2 mutant shows a 
reduction in the number of macrophages and neutrophils in the absence of infection. 
In addition, our studies revealed that ikk2 mutation led to blocking of the insulin 
resistance induced by hyperinsulinemia. This indicates that the ikk2 mutation might 
represent a null allele of this gene. 
 
Results and discussions  
Studies of a Traf6 mutant 





The traf6sa244 mutant carries a guanine to thymine (G to T) point mutation that 
generates a premature stop codon located at the nineteenth amino acid close to the N-
terminus of the RING domain (Fig. 1A). Theoretically, this leads in the homozygous 
situation to a complete absence of the Traf6 protein and prevents Traf6-mediated 
downstream signaling. To get rid of many of the background ENU mutations in the 
traf6 mutant zebrafish, we conducted outcrosses between the wildtype and this 
mutant line (Fig. S1). The offspring from the fifth generation (F5) were used to conduct 
experiments in our study. 
 
2 traf6 mutation affects the survival rate of zebrafish larvae 
We performed an incross between the F0 generation of Traf6 heterozygotes, and only 
one male Traf6 homozygote offspring survived. This homozygote male was outcrossed 
to wildtype (AB/TL) to obtain the F2 generation of Traf6 heterozygotes (Fig. S1). Two 
groups of traf6sa244/sa244, and traf6+/+ larvae from the third generation (F3) (Fig. S1) were 
compared under normal embryo raising conditions to test for differences in 
unchallenged survival during development. Up to 7 dpf there was no difference in 
survival between mutants and wildtypes (Fig. 1B). After this period, traf6sa244/sa244 larvae 
showed a significantly decreased survival rate (75% survival) compared with traf6+/+ 
larvae (95% survival) (Fig. 1B). The steady mortality rates of traf6sa244/sa244 larvae ceased 
at around 20 dpf. Thus, under our raising conditions, 8-20 dpf was a crucial period for 
raising traf6sa244/sa244 larvae in this generation. Subsequent development of 
traf6sa244/sa244 was normal with the larvae reaching adulthood in a normal time span 
leading to adults with a normal fertility rate at the expected time period. Furthermore, 
traf6sa244/sa244 adults did not display any increased mortality rate compared with 
wildtype individuals and heterozygotes, or showing pathological features linked with 
infection. 
    In mice, Traf6 deficiency is known to influence bone development, for example 
Traf6-/- mice exhibit severe osteopetrosis and are defective in osteoclast formation (44) 
and Traf6 is involved in TNF-alpha-induced osteoclastogenesis (45). We therefore 
measured the body size of traf6sa244/sa244 and traf6+/+ zebrafish larvae at 5dpf (Fig. 1C). 
We found that there is no significant difference of the body size between traf6sa244/sa244 
and traf6+/+ larvae.  
 
3 traf6 mutation does not prevent activation of TLR signaling in zebrafish larvae 
The premature stop codon in the mutant allele is predicted to lead to the disruption of 
almost the complete reading frame encoding the Traf6 protein. The resulting 






FIGURE 1 Description of the Traf6 mutant. A, mutant sequence and protein structure. A point 
mutation (G to T) in the codon for the nineteenth amino acid close to the N-terminus of the RING 
domain of zebrafish traf6 introduces a premature stop codon. Nucleotide and amino acid positions 
are indicated with respect to the translation start codon. B, survival assays. Percentage survival 
during the first 20 days of development (under unchallenged conditions) is shown for two groups 
(n=70×3 per group) of traf6sa244/sa244 mutants (red line) and traf6+/+ wildtype (blue line), grown in 
three separate tanks. The groups are the F3 offspring of traf6sa244/sa244 and traf6+/+ siblings born from 
heterozygous parents. At 21 dpf, 95% of traf6+/+ survived, 75% of traf6sa244/sa244 mutants survived. The 





with a log rank test. C, body size measurement. Zebrafish larvae were imaged by stereo microscopy, 
and the body sizes were measured from traf6+/+ and traf6sa244/sa244 (n>30). D, traf6sa244/sa244 and traf6+/+ 
embryos were injected at 27 hpf with 1 ng Pam3CSK4 or 0.1 ng flagellin and expression levels of il1b 
were determined at 1hpi by qPCR. Data (mean ± SEM) are combined from at least three biological 
replicates (n=10 embryos per group) and expressed relative to their corresponding mock injection 
(water) control, which is set at 1. Statistical significance of differences was determined by two-way 
ANOVA with Sidak Multiple Comparison test as a post-hoc test, ***p<0,001. E-F, relative 
fluorescence pixel-count analysis of whole body number of mCherry-labeled macrophages and GFP-
labeled neutrophils in 2dpf traf6+/+/Tg(mpeg1:mcherry/mpx:gfp) and traf6sa244/sa244/Tg(mpeg1: 
mcherry/mpx:gfp) embryos (n>30) were performed based on stereo fluorescence imaging. No 
significant differences were observed in both macrophages and neutrophils phenotype with a T-test.  
 
activate TAK1/TABs, is expected to inhibit all TLR downstream signaling, including 
MAPK- and IKK complex-induced AP1 and NF-κB activation. 
    To confirm whether this traf6 mutation blocks the downstream TLR signaling 
pathway, we analyzed the expression level of the inflammation marker gene il1b in 
zebrafish embryos upon injection with the TLR2 agonist Pam3CSK4 and the TLR5 
agonist flagellin. Pam3CSK4 and flagellin were injected into the blood island of 
zebrafish embryos at 27 hpf. One hour post injection (hpi), we collected samples and 
conducted qPCR. We injected water (solvent for Pam3CSK4 and flagellin) as a control 
for which the gene expression level was set at 1 (Fig. 1D). In traf6sa244/sa244 the 
expression level of il1b unexpectedly showed a significantly higher induction than that 
in traf6+/+ upon flagellin injection, which remains unexplained (Fig. 1D). There was no 
significant difference of il1b expression between traf6sa244/sa244 and traf6+/+ upon 
Pam3CSK4 stimulation (Fig. 1D). These results show that the traf6 mutation in our 
study does not block the TLR downstream signaling as we expected.  
 
4 Macrophage and neutrophil phenotype in traf6 mutant larvae  
GM-CSF and M-CSF promote macrophage proliferation, survival and differentiation 
through TRAF6-dependent AKT activation (46-50). A recent publication reported that 
the inhibition of TRAF6-mediated AKT activation is involved in macrophage 
proliferation regulated by CKIP (51), so our prediction is that a traf6 mutation may 
influence the number of leukocytes in zebrafish. To study this we crossed traf6sa244/sa244 
into double transgenic Tg(mpeg1.1:mCherryF/mpx:GFP) fish, allowing the visualization 
of macrophages and neutrophils respectively. First, we analyzed leukocyte number by 
fluorescence pixel-count analysis of macrophages and neutrophils in 2dpf 







GFP) embryos. We observed no significant difference in the number of macrophages 
and neutrophils in the mutant (Fig. 1E-F). 
 
5 Mycobacterium marinum infection in traf6 mutant larvae 
We performed two individual yolk infection assays with Mycobacterium marinum E11 
(MmE11) strain in the traf6 mutant. We injected 64-128 cell stage embryos with ~40 cfu 
MmE11 by yolk injection, and conducted COPAS analysis at 3, 4 and 5 dpf (Fig. 2). The 
traf6 mutant showed a decreased bacterial burden at 4dpf but not at 3 and 5 dpf (Fig. 
2). Therefore we conclude that the traf6sa244mutant allele does not have a major effect 
on host defense against Mm. 
 
6 Western blot analysis of the Traf6 mutant 
Considering the unexpected results of the phenotypic screening of the Traf6 mutant 
we tried to confirm that the mutation leads to a complete absence of Traf6 protein in 
zebrafish. Therefore we performed western blot analysis in 1dpf traf6 morphants and 
4dpf wt and mutant larvae (Fig. 3) using a commercially available monoclonal antibody 
against human TRAF6 protein. There was one band with a size close to the positive 
control TRAF6 protein from human Jurkat cells (58 kDa). The size of the predicted 
Traf6 protein in zebrafish is 62 kDa. The relative expression of this band that might 
represent zebrafish Traf6 was compared between different zebrafish samples using 
ImageJ analysis. The results showed that there was no significant difference of protein 
expression between wildtype and traf6 morphants or traf6 mutant larvae. One of the 
explanations for this result is that this protein band is not representing the Traf6  
FIGURE 2 Quantification of bacterial burden 
in traf6+/+ and traf6sa244/sa244 larvae. Embryos 
were infected at 64-128 cell stage with ~40 
CFU MmE11 strain. COPAS analysis were 
used for quantification of bacterial burden. 
Data (mean ± SD) are combined from two 
individual yolk infection assays . Statistical 
significance of differences was determined 
by one-way ANOVA with Tukey’s Multiple 
Comparison method as a post-hoc test. 









protein and that the antibody was not able to detect zebrafish Traf6 due to an aspecific 
background band. This is argued by the absence of an effect in the samples from 
treatment with a Traf6 translation blocking morpholino, which was previously shown 
to affect embryo development as well as the expression of immune effector genes 
downstream of Traf6 signaling (43). The other explanation is that the traf6 mutation 
does not result in a null mutant at the protein level and that the traf6 morpholino 
treatment isnot sufficiently penetrant to show an effect at the protein level.  
 
7 Conclusion 
In conclusion we can propose two possible explanations for the shown results. 
FIGURE 3 Western blot analysis of Traf6. Western blot results of whole 1 dpf embryos (traf6 
morphants and wildtype, upper two-panels) and 4 dpf larvae (traf6 mutant and wildtype, lower two-
panels) are shown. Relative expression data (mean ± S.E.M.) are determined from two (wt) or three 
(traf6 MO, traf6+/+, traf6-/-) biological replicates (n=100 embryos (1dpf)/group (upper panel), n=15 
larvae (4dpf)/group (lower panel)) and expressed relative to the positive control (+, whole protein 
from 4dpf AB/TL wildtype fish line), which is defined as 1. A protein sample of human Jurkat cells is 





Firstly, the point mutation from G to T at position 55 bp after the predicted start 
codon of Traf6 does not lead to a null phenotype traf6 mutant. We hypothesize that 
there could be an alternative start codon close to the mutation point that leads to 
reinitiation of translation of Traf6. We did find that there is another ATG at the 
position 79 bp in the coding sequence (Fig. 1A) that if used as an alternative start 
codon would lead to a slightly shorter Traf6 protein. Although various of the amino 
acids in the resulting deletion are conserved in the mammalian counterparts, the 
entire RING domain would not be affected and therefore it is conceivable that the 
resulting protein might be at least partially or perhaps fully functional. However, we do 
not know how likely this hypothesis is, since to our knowledge the capacity of the 
zebrafish translation machinery to restart translation shortly after a stop codon that 
pertubs a natural reading frame is currently unclear.  
Secondly, another explanation is that the traf6 mutation effect has been rescued by 
another mutation in the genome that resulted from the saturating ENU methodology 
used for mutagenesis that was not bred out of the original founder line. An indication 
for this is that we only obtained one single homozygote after the first generation 
incross. Such a suppressor mutation could have led to misregulation of homologs of 
Traf6 that might take over the function of Traf6. It is also possible that the Traf6 
mutation is suppressed by mutation of unrelated proteins that function in the TLR or 
TNF signaling pathways. This would be similar to the published suppression of 
mutants of Ikk2 by mutations in Tnfr1 (52). Li et al (52) showed that mice double 
mutants of Tnfr1-/-/Ikk2-/- can survive until one month rather than die around 12.5-13.5 
days like the Ikk2-/- mutant. They demonstrated that the rescue of embryonic lethality 
of Ikk2 deficiency by inactivation of Tnfr1 is caused by the inhibition of Tnfa-induced 
hepatocyte apoptosis. If Traf6 protein indeed is essential for development in zebrafish 
(as suggested by our previous morpholino results (43)) it is very much possible that we 
have selected for suppressor mutations during our incrossing schemes. An indication 
for this is the higher levels of lethality of larvae resulting from incrosses at the third 
generation after 7 days of development post fertilization (Fig.1B). For instance, it is 
possible that the larvae that died represent a population in which the suppressor 
mutation was lost or that the surviving population have optimized the effect of the 
suppressor mutation via epigenetic regulatory mechanisms.  
In order to resolve these questions and to proceed with further studies of Traf6 in 
zebrafish it is needed to construct new mutants for comparative studies. Fortunately, 
during the time that this study was performed the new CRISPR/CAS technology has 
been made suitable for the efficient generation of targeted mutations also in zebrafish 
(53, 54). However, this study also illustrates that a limiting factor in zebrafish mutant 
studies is the lack of reliable antibodies against the studied signaling proteins. The 
availability of good antibodies against zebrafish Traf6 protein will remain extremely 





Studies of an Ikk2 mutant 
1 General characterization of ikk2 expression and ikk2 mutant zebrafish embryos 
To show the transcription expression pattern of ikk2 in zebrafish embryos, we collected 
RNA from wildtype (AB/TL) embryos to perform a time course qPCR series at different 
stages, which included oblong (3.7 hpf), germ ring (5.7 hpf), bud (10 hpf), 20-somite (19 
hpf), 24 hpf, 48 hpf, 60 hpf and 72 hpf (Fig.4A). We found that the expression level of 
ikk2 starts to show a stabilized expression from the 20-somite stage (19 hpf) until the 
last time point (72 hpf) of the assay (Fig.4A). 
An ikk2m10 mutant was obtained from Dr. Vladimir Korzh’s lab. These researchers 
developed this mutant by zinc finger nuclease-mediated mutagenesis. The ikk2m10 
mutant carries an insertion mutation from AC to ATGC that creates a premature stop 
codon (Fig. 4B). The position of this stop codon located in the N-terminus of the 
kinase domain of zebrafish Ikk2 leads to a gene reading frame shift at the codon of the 
tenth amino acid and introduces a premature stop codon at the predicted sixty first 
amino acid. Technically, this should lead to a complete absence of the Ikk2 protein and 
prevent downstream signaling. Korzh et al. found that homozygote mutants carrying 
this predicted null allele showed survival rates comparable to wildtype from the one-
cell stage until three months post fertilization, but decreased body lengths at nine 
months of age (unpublished data).This is in agreement with a previous study that 
shows that endothelial-specific Ikk2 knockout mice were ~25% smaller than the 
control (55). We measured the body length of zebrafish ikk2 mutants at 3dpf, and 
found that, compared to their siblings control ikk2+/+, ikk2m10/m10 showed a significant 
shorter body length (Fig. 4C). This result is therefore in good agreement with the 
earlier unpublished studies of Khorz et al. and shows that this phenotype is already 
detectable at a very early stage of development. 
To determine the RNA expression pattern of ikk2 in the ikk2 mutant, total RNA was 
isolated from embryos and qPCR was performed at 20-, 33-, 48- and 72 hpf. We found 
that the ikk2 mutant showed a significant upregulation of the ikk2 mRNA level at 3dpf 
(Fig. 4D). This suggests that the ikk2 mutant induces an overexpression of ikk2 at the 
transcriptional level in zebrafish early stage development or that the ikk2m10 mRNA is 
more stable than the wild type ikk2 mRNA. This may indicate a negative feedback 
regulation of Ikk2 on its own expression level. 
To determine whether the ikk2 mutation inhibits NF-κB activation, we injected TLR5 
agonist, flagellin, into the blood island of zebrafish embryos at 28 hpf and checked il1b 
expression at 1hpi as previously described (56). We found that il1b shows a significant 
upregulation in the ikk2 mutant, and that the induction of the expression level was 
even much higher than in ikk2+/+ larvae (Fig. 4E). This is a surprising result since the 






FIGURE 4 Characterization of ikk2 and ikk1 mRNA expression in the ikk2m10 mutant. A, mRNA 
expression analysis of ikk2 from 3.7 to 72hpf in wildtype (AB/TL). B, ikk2 mutant sequence and 
protein structure. An insertion mutation of two bases (AC to ATGC) in the N-terminal sequence of the 
kinase domain of zebrafish Ikk2 leads to a frame shift at the codon for the tenth amino acid and 
introduces a premature stop codon at the sixty first amino acid. The truncated protein lacks the 
whole Ikk2 protein. Nucleotide and amino acid positions are indicated with respect to the mutation 
position. C, larvae of ikk2+/+ and ikk2m10/m10 were imaged using stereo microscopy and their body 





****p<0,0001. D, the mRNA expression of ikk2 from 20hpf to 3dpf in ikk2+/+ and ikk2m10/m10 larvae. E, 
il1b mRNA expression in ikk2+/+ and ikk2m10/m10 embryos at 1hpi after flagellin blood island injection. F, 
the mRNA expression of ikk1 from 20hpf to 3dpf in ikk2+/+ and ikk2m10/m10 larvae. Statistical 
significance of differences in D-F was determined by two-way ANOVA with Sidak Multiple 
Comparison test as a post-hoc test, ***p<0,001, ****p<0,0001.  
 
should disrupt its function of phosphorylating IκB molecules, the inhibitors of NF-κB 
transcription factors. These disruptions will subsequently inhibit the release and 
nuclear translocation of NF-κB. 
 
2 the Ikk2 mutation induces a temporary upregulation of Ikk1  
Theoretically, phosphorylation of IKK2 is necessary for activation of the canonical NF-
κB pathway (57) and IKK1, also known as IKKα or CHUK, is necessary for activation of 
the non-canonical or alternative pathway (58). Functioning as one of the catalytic 
subunits of the IKK complex, IKK1 shows a similar structure as IKK2 (59). A previous 
study in human lymphoma cells showed that IKKα may directly phosphorylate IκBα 
under conditions of IKKβ inhibition contributing to cell survival. Therefore, we studied 
the gene expression level of ikk1 in ikk2m10/m10 embryos and larvae. As the results show 
(Fig. 4F), the expression level of ikk1 was significantly upregulated at 20 and 33hpf in 
ikk2m10/m10 compared to ikk2+/+ embryos, but after that it decreased to the normal level 
as shown in the Ikk2+/+ larvae at 2 and 3dpf. These results suggest the hypothesis that 
ikk2 deficiency may lead to ikk1 overexpression in zebrafish embryos at an early stage, 
which induces a compensatory activation of the canonical NF-κB pathway.  
 
3 The ikk2 mutant shows a deficient phenotype of leukocytes and is more susceptible to 
infection with Mycobacterium marinum than the wildtype 
To characterize the phenotype of immune cells in ikk2 mutant embryos, we performed 
a combination of TSA and L-plastin immunostaining in embryos at 2 and 3dpf (Fig. 5A, 
B). Cells labeled with TSA are neutrophils, and those labeled with L-plastin represent 
all leukocytes (i.e. neutrophils and macrophages). We found that there is a significant 
decrease in the number of neutrophils at 2dpf but not at 3 dpf (Fig. 5A, B). 
Furthermore, the total number of leukocytes seemed reduced at both 2 and 3 dpf, 
although not reaching the significance threshold (Fig. 5A, B). To confirm these result, 
we conducted qPCR to detect the transcript level of the genes mpx and mpeg1 (Fig. 5C, 
D), which are marker genes of neutrophils and macrophages respectively. The 






FIGURE 5 Study of leukocytes and mycobacterial infection in the Ikk2 mutant. A, B, quantification of 
leukocyte numbers. The number of neutrophils and macrophages was determined by performing 
whole mount L-plastin immuno-histochemistry (total leukocytes) combined with TSA staining 
(neutrophils) in 2 and 3dpf zebrafish larvae (n>=27). Statistical significance of differences was 
determined by t-test, *p < 0.05, **p<0,01. C, D, mRNA expression levels of mpx and mpeg1 were 
determined by qPCR from 20hpf to 3dpf. E, quantification of bacterial burden. ikk2+/+ and ikk2-/- 
embryos were infected at 28hpf with ~150CFU Mma20 strain. Stereo fluorescence images of Mm 
infected embryos at 4dpi were used for quantification of bacterial fluorescence pixels. Statistical 






mutant at 2 and 3dpf (Fig. 5C, D). Our results indicate therefore that in the ikk2 
mutant both neutrophil and macrophage development is affected. 
Considering the deficiency of macrophages and neutrophils in the ikk2 mutant at an 
early developmental stage, we performed an infection assay with Mycobacterium 
marinum m20 (Mma20) through blood island injection at 28hpf and detected the 
bacterial burden at 4dpi. The result shows that the ikk2m10/m10 mutation promotes an 
increase of bacterial proliferation compared to the sibling control (Fig. 5E). 
The effect of a mutation of Ikk2 on immune responses was also demonstrated in 
rodents. For instance, compared to the wildtype , mice with Ikk2 deficiency in lung 
epithelial cells exhibited a delayed onset of Th17 and B cell responses in the lung and 
delayed fungal clearance. Importantly, delayed Pneumocystis clearance in Ikk2-
deficient mice was associated with an exacerbated immune response, impaired 
pulmonary function, and altered lung histology. These data demonstrate that Ikk2-
dependent lung epithelial cell responses are important regulators of pulmonary 
adaptive immune responses and are required for optimal host defense against 
Pneumocystis infection (25).  
 
4 The mutation of ikk2 modulates the insulin resistance induced by hyperinsulinemia 
Mice with Ikk2 deficiency in myeloid cells retain global insulin sensitivity and are 
protected from insulin resistance (60). Zebrafish has been shown to be a good model 
to study acute insulin resistance induced by hyperinsulinemia in a previous study from 
our laboratory (61). To study how the ikk2 zebrafish mutant responds to 
hyperinsulinemia, we injected insulin into the caudal aorta at 4dpf, and the second 
injection was conducted 240 minutes later following the protocol published previously. 
A glucose measurement was performed at 0, 30 and 240 minutes after the first 
injection and 30 minutes after the second injection. The results show a typical insulin 
resistance in wildtype larvae after the second injection, where they exhibited a 
significant higher glucose level (Fig. 6A). The result also show that there was no 
upregulation of the glucose level in ikk2m10/m10 after the second insulin injection (Fig. 
6C). We outcrossed the ikk2m10/m10 mutant with the wildtype (AB/TL) leading to an 
offspring called ikk2+/-. We found that in this heterozygote the glucose level increased 
after the second insulin injection as in the wildtype control (Fig. 6B).  
    To further study the role of IKK2 in insulin resistance, we measured the 
transcriptional level of the phosphoenolpyruvate carboxykinase 1 gene (pck1), which is 
well known to be inhibited by insulin in mammals and zebrafish (62). As expected we 
found that the expression level of pck1 in the wildtype was decreased after insulin 






FIGURE 6 Studies of responses to hyperinsulinemia in the ikk2 mutant. A-C, Zebrafish larvae from 
wildtype (A), ikk2+/- (B) and ikk2-/- (C) were injected with 1nl human recombinant insulin at 100 nM in 
the caudal aorta at 4 dpf and received a second injection at 4 hpi (240 min). Control larvae were 
injected with PBS. Samples for glucose measurements were taken at 0, 30, and 240 min after the first 
injection and 30 min after the second injection. Values in the scale are indicated in minutes post 
injection (mpi). Data (mean ± SE) are combined from 3 biological replicates (n= 4 or 5 larvae per 
group). D-F, mRNA expression level of pck1 from wildtype (D), ikk2+/- (E) and ikk2-/- (F) were 







showed a similar result as in the wildtype (Fig. 6E). In contrast, for the ikk2m10/m10 , the 
expression level of pck1 showed an increase after the insulin injection (Fig. 6F). These 
results indicate that the inhibition of pck1 induced by insulin is reversed in the ikk2 
mutant.  
Our zebrafish Ikk2 mutant has demonstrated its value for studying a role of IKK2 in 
responses to insulin. The mechanism underlying these results might be related to the 
degradation of S6K protein in the absence of IKK2 activation (63). This suggestion is 
based on a previous report of Um et al. (64) who reported that knockout of S6K 
protected mice from obesity-induced insulin resistance. However, the conclusion that 
Ikk2 deficiency reverses insulin resistance has also been challenged by the study of 
Rohl et al (65), who showed that Ikk2 expression in mice skeletal muscle is not 
essential for obesity-induced insulin resistance in mice (65). Considering these 
conflicting results, additional studies of the function of IKK2 in insulin resistance are 
necessary. We expect that our zebrafish mutant will be of great use for such studies. 
 
General conclusions 
TLR signaling is involved in a multitude of physiological and pathological processes. 
The derivative question is how TLR signaling can be involved in so many processes? 
Therefore the mediators in TLR signaling have become major research targets. In the 
last decade, construction of mutations in rodent models became a common strategy to 
study the function of important genes in TLR signaling. However, the global deficiency 
of most of them has been shown to lead to a lethal phenotype in mice, and therefore 
the zebrafish model becomes a prominent candidate for further studies because of its 
suitability for studies at the embryonic and larval stages. For example, in our study the 
Ikk2 mutant was shown to be a potential model to study the mechanism of acute 
insulin resistance in the larval stage. This is based on our conclusion that in the 
ikk2m10/m10 mutant the acute insulin resistance induced by hyperinsulinemia was 
modulated. Furthermore, the Ikk2 zebrafish mutant showed defects in development 
and immunity, such as decreased body length, lower leukocyte numbers, lower 
expression level of marker genes of immune cells and higher bacterial proliferation 
upon Mm infection. Unexpectedly, we found that the ikk2 mutant induced an 
overexpression of ikk1, which may play a compensatory role in NF-κB activation and 
il1b expression. In future research, the Ikk2 deficiency model provides a chance to 
further study the interaction between the innate immune system and metabolic 
diseases.  
In addition, we can also expect that an effective mutant of Traf6 can be generated in 
the near future, which not only can be applied in studies of immune-related diseases 





reported that blocking Cd40-Traf6 signaling is a therapeutic target in obesity-
associated insulin resistance in mice (66).  
 
Materials and methods 
Zebrafish husbandry  
The traf6sa244 mutant allele was identified by sequencing of an ENU-mutagenized 
zebrafish library. The mutant line was obtained from the Sanger Institute Zebrafish 
Mutation Resource. We performed an incross between the F0 generation of Traf6 
heterozygotes, and only one male Traf6 homozygote offspring survived. Outcrosses of 
the heterozygote lines unfortunately did not survive and therefore we could only 
continue with the incrossed homozygote line. The ikk2m10 mutant allele was obtained 
from Dr. Vladimir Korzh from the Institute of Molecular and Cell Biology (Singapore). 
Heterozygous and homozygous carriers of the mutation were outcrossed twice with 
the wildtype (AB/TL strain), and were subsequently incrossed twice. Homozygous fish 
of the resulting family were used to produce embryos. 
    Wildtype zebrafish of the AB/TL strain and strains traf6sa244/sa244, traf6+/+, 
traf6sa244/sa244/Tg(mpeg1.1:mCherryF/mpx:GFP), traf6+/+/Tg(mpeg1.1:mCherryF/mpx:GFP), 
ikk2m10/m10 and ikk2+/+ strain were handled in compliance with the local animal welfare 
regulations and maintained according to standard protocols (zfin. org). Embryos and 
larvae were raised in egg water (60g/ml Instant Ocean sea salts) at 28.5 °C. For the 
duration of bacterial injections, larvae were kept under anesthesia in egg water 
containing 0.02% buffered 3-aminobenzoic acid ethyl ester (Tricaine, Sigma-Aldrich, 
the Netherlands). The culture of zebrafish carrying mutations that might cause 
immune deficiencies was approved by the local animal welfare committee (DEC) of the 
University of Leiden. All protocols adhered to the international guidelines specified by 
the EU Animal Protection Directive 2010/63/EU.  
Bacterial strain preparation 
The bacterial strains, Mycobacterium marinum (ATCC#BAA-535) m20 (Mma20) and E11 
(MmE11), containing the plasmid pSMT3-mCherry (67), were used for the infection of 
zebrafish larvae. For the infection assay, bacteria were prepared as previously described 
(68), where the injection inoculum was prepared in 2% polyvinylpyrrolidone40 (PVP40) 
solution (CalBiochem), and 150 colony-forming units (CFU) of Mma20 were injected 
into the blood stream at 28 hours post fertilization (hpf) as previously described (68). 
For the yolk injection, 40 CFU of MmE11 were injected into the yolk around the 64 cell-






Purified Pam3CSK4 (InvivoGen, France) and flagellin from S. typhimurium (Flagellin 
FliC VacciGrade™, Invitrogen, France) were diluted in 1 mg/ml and 100 μg/ml in sterile 
water, respectively. For injection, 1 nl of the ligand solutions were injected into the 
blood stream at 28hpf. Sterile water was injected as a control experiment. Injections 
were performed using a FemtoJet microinjector (Eppendorf, the Netherlands) 
equipped with a capillary glass needle.  
Insulin injection 
To inject PBS and human recombinant insulin (Sigma–Aldrich, the Netherlands), 1 nl 
was injected into the caudal aorta of 4 dpf zebrafish larvae using a glass capillary. 
Glucose measurements 
Glucose measurements were done using a fluorescence-based enzymatic detection kit 
(Biovision, Inc., Mountain View, CA, USA) as described previously (69). 
Morpholino injections  
Morpholino oligonucleotides (Gene Tools) were diluted to desired concentrations in 1× 
Danieu’s buffer (58mM NaCl, 0.7mM KCl, 0.4mM MgSO4, 0.6mM Ca (NO3)2, 5.0mM 
HEPES (pH 7.6)) containing 1× phenol red (Sigma-Aldrich). For knockdown 
experiments, traf6 ATG-morpholino (traf6 mo, 5'-GCCTATACTGCTGCTTCCTGTAA 
AG-3’) was injected with the optimal concentration at 0.5 mM and 1nl volume per 
embryo at 0~2 cell stage. Control larvae were injected with the standard control 
morpholino (Sc mo, 5'- CCTCTTACCTCAGTTACAATTTATA-3').  
Immunohistochemistry 
Embryos or larvae were fixed in 4% paraformaldehyde in PBS overnight at 4°C. Mpx 
activity was detected with TSA (TSA plus kit, Fluorescence Systems, Perkin Elmer Inc., 
Waltham,MA) as previously described (70). Immunostaining with L-plastin antibody 
(71) and the secondary antibody was as described (72). 
Infection assays and imaging  
Zebrafish larvae were staged at 28 hours post fertilization (hpf) by morphological 
criteria (73), and ~150 CFU of Mma20 m-cherry strain were injected into the blood 
island under the dorsal aorta, sterile PBS injection using as negative control. Injections 
were controlled using a FemtoJet microinjector (Eppendorf) and a micromanipulator 
with pulled microcapillary pipettes. Pools of around 20 larvae were collected at 3- and 
4-day post infection (dpi) and performed imaging on a Leica MZ16FA Fluorescence 
Stereo Microscope. Bright field and fluorescence images were generated with a Leica 





counting software as previously described (74). Experiments were performed in 
triplicate.  
COPAS analysis 
Zebrafish larvae were injected with ~40 CFU of MmE11 m-cherry strain at 64 cell stage, 
and the bacteria burden was measured with COPAS at 3, 4 and 5dpf as previously 
described (75). 
Western blot analysis 
Western blot analysis were performed as previously described (61).Whole 
homogenized zebrafish 1dpf embryos (n=100/sample) or 4dpf larvae (n=15/sample) 
were prepared for protein isolation. The protein concentration was determined using a 
BCA Protein Assay Kit (Thermo Scientific, Rockford, IL, USA). The extracted protein 
samples were subjected to SDS–PAGE and transferred onto nitrocellulose membranes 
(Bio-Rad). The primary antibody is anti-TRAF6 (Abcam, EP591Y), and Pan-actin (Cell 
Signaling, no. 4968) was used as a loading control. Finally, the bands were quantified 
by densitometry using ImageJ Software (National Institutes of Health, Bethesda, MD, 
USA). The bands were quantified by densitometry using ImageJ 64 Software (National 
Institutes of Health). 
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CHAPTER 5  





Scientists started to address the issue of innate immune specificity about thirty years 
ago, when the interleukin 1 receptor was cloned in 1988 (1) and Charles Janeway (2) 
proposed the concept of pattern recognition receptors (PRRs) in 1989. Toll-like 
receptors are representative members of the group of PRRs. Human TLR4 was first 
identified as the signaling receptor for lipopolysaccharide (LPS) in 1989, initiating 
intensive research on the other TLR family members in mammals (3). TLRs are highly 
conserved across different vertebrate species. After recognition of specific pathogen 
associated molecular patterns (PAMPs) from microbes or damage associated molecular 
patterns (DAMPs) from damaged tissue, TLRs mediate the activation of downstream 
NF-κB, MAPK and AP-1 signaling pathways involved in host defense against invading 
pathogens and maintaining homeostasis.  
Zebrafish have a 3-4 weeks separation stage between development of innate and 
adaptive immunity after fertilization (4, 5), which gives the possibility to study the host 
innate immune response to infection in the absence of adaptive immunity responses. 
In the beginning of our study, there was little known about the function of TLR 
signaling in zebrafish larvae. In this thesis I studied the functions of the zebrafish 
orthologs of the human TLR5 and TLR2 genes that were shown to be responsible for 
recognition of bacterial flagellin and a broad spectrum of bacterial cell wall 
components, respectively. One of the focal points of this thesis is the difference at the 
transcriptomic level of the downstream pathway of the TLR5 and TLR2 receptors and 
the roles of TLR signaling in host innate immune responses to infection by 
Mycobacterium marinum, a close relative to Mycobacterium tuberculosis and a natural 
pathogen of zebrafish. The new possibilities for analysis of transcriptomes using RNA 
deep sequencing make it highly attractive to analyze the responses of an entire test 
animal model at the system biology level. Furthermore, we used genetic knockdown 
and knockout tools to further analyze the function of TLR5 and TLR2 and downstream 
signaling partners in innate immunity, infectious disease and insulin resistance.  
In chapter 2, we demonstrated that Tlr2 signaling functions similarly in zebrafish 
embryos as in mammalian cells through regulating immune gene expression after 
TLR2 ligand systemic stimulation. For this study we used the compound Pam3CSK4 
which is a synthetic lipopeptide which can mimic the acylated amino terminus of 
bacterial lipoproteins, and is often used to trigger TLR2 activation in mammalian cells. 
Further comparative analysis of transcriptomic profiles of Tlr2 and Tlr5 signaling upon 
Pam3CSK4 and flagellin stimulation, respectively, were conducted using RNA deep 
sequencing. The results show that there is a relatively limited overlap between the 
transcriptome responses towards Pam3CSK4 and flagellin. The overlap includes well 
known downstream immune mediators that were previously shown to be induced by 
flagellin such as il1b, tnfa, irak3, mmp9, cxcl-c1c and il8. In contrast, il6 and il10, that are 
associated with an anti-inflammatory response, were induced much stronger by 





differential response to flagellin or Pam3CSK4, including a group of genes of which the 
transcription is specific for activation by one of the two treatments. In the Pam3CSK4 
specific set, we identified a group of transcription factors with more than 2 fold-change 
in expression, as confirmed by qPCR analyses, including cebpb, fosb, nr4a1 and egr3. 
We also showed that the regulation of the gene sets that were specifically responding 
to Pam3CSK4 and flagellin were inhibited by knockdown of tlr2 or tlr5, respectively. 
Our studies show that Pam3CSK4 and flagellin can stimulate the Tlr2 and Tlr5 
signaling pathways leading to common and specific responses in the zebrafish larval 
system.  
To further study Tlr2 function in host defense against mycobacterial infection, we 
developed a tlr2 mutant-M. marinum infection model in Chapter 3. The Tlr2-specific 
genes shown in Chapter 2 also show a significant upregulation upon M. marinum 
infection. In contrast, the tlr2 mutant showed a defect in the response of the 
expression level of these genes to infection. In addition, the tlr2 mutant showed a 
reduced number of macrophages in the absence of infection, which might be 
attributed to a defect in the emergence and differentiation of hematopoietic stem and 
progenitor cells. The TLR2 agonist Pam3CSK4 was shown to induce a large proportion 
of human hematopoietic stem cells to express markers of the myelomonocytic lineage 
(6). Herman et al. (7) also showed that systemic exposure of mice to a TLR2 agonist 
leads to an expansion of bone marrow and spleen phenotypic hematopoietic stem cells 
and progenitors, which supports a role for TLR2 in the regulation of hematopoietic 
stem cells.  
The tlr2 mutant also shows a higher mycobacterial proliferation and a reduced 
number of granulomas in the presence of infection. However, our results suggest that 
the macrophage migration speed and maximum migration distance from infection 
sites of phagocytic macrophages, are significantly higher in the tlr2 mutant than in the 
tlr2 heterozygote control. This could indicate that the Tlr2-deficient macrophages are 
less active in phagocytosis which might contribute to the higher bacterial proliferation 
in the tlr2 mutant. These results suggest that Tlr2 might be playing a role in 
macrophage congregation and phagocytosis and is involved as a protective factor in 
host defense against mycobacteria.  
Subsequently, we performed RNA deep sequencing of tlr2 mutant and heterozygote 
larvae after M. marinum infection, and analyzed the transcriptomic profiles. We found 
that tlr2 mutation led to far less upregulation and downregulation of immune response 
genes after M. marinum infection. Many of these genes are involved in lysosome 
processes, chemotaxis, transcription regulation, and other immune processes, or 
encode diverse immunoglobulin domain-containing proteins (dicps). In addition we 
also identified genes involved in other processes, such as oxidation-reduction process, 




relationship between the genes that are differentially expressed, we constructed 
networks based on common expression targets. For instance, we found that the 
vitamin D receptor pathway genes that are normally up-regulated during infection in 
zebrafish larvae were down regulated in the tlr2 mutant. Vitamin D has been shown to 
be an important regulatory factor during tuberculosis (8) and has been linked 
previously to TLR2 function in studies in cell cultures (9).  
In addition, the transcriptome profiles of the tlr2 mutant and heterozygote were 
analyzed in the absence of infection. We found that the largest category of genes of 
which the transcriptional level was significantly affected, were linked to neurological 
system processes. When focusing on the possible signaling pathways that could be 
involved we observed that there was a significant effect in the GO category of 
transcription factors, particularly the c-Maf factors totaling up to 546 representatives 
that were affected. Considering the role of Maf family transcription factors in 
macrophage self-renewal, these results might indicate a link to the effect of the tlr2 
mutation on the number of macrophages in the absence of infection.  
Furthermore, we also conducted Gene-Set Enrichment Analysis to our deep 
sequencing data with p-value less than 0.05. We screened 61 pathways in the tlr2 
heterozygote and 67 pathways in the tlr2 mutant related to metabolism, immunology 
and inflammation, respectively. Most of these pathways respond in a common way in 
both groups showing that the tlr2 mutant still retains most metabolic and 
immunological responses to M. marinum infection. Subsequently, we performed Sub-
Network Enrichment Analysis to identify possible key genes that are responsible for 
the difference in response of the tlr2 heterozygote and mutant groups to M. marinum 
infection. In addition to 301 common pathways from both groups, there are 264 tlr2 
related specific pathways in zebrafish. These 264 pathways were compared to gene sets 
that were shown to be responding to M. tuberculosis infection (10) in human 
macrophages showing 56 common pathways. Of these common pathways, the pathway 
of TLR8 has the lowest p-value in both enrichments, which suggests that Tlr2 signaling 
is strongly connected with Tlr8 function. Furthermore, pathway analysis in the tlr2 
mutant (Chapter 3, Fig. S5 and S7) also implicated that the expression of the Tlr8 
pathway is connected to vitamin D signaling. TLR8 mutations (polymorphisms) 
increase susceptibility to mycobacteria (11, 12). These predictions from integrated 
transcriptome analysis give further incentives to study the function of TLR8 signaling 
in our future work.  
In addition to being involved in innate immune defense against mycobacterial 
infection and insulin resistance, TLR-dependent signaling is also required to maintain 
compartmentalization of the gut microbiome of mice (13). TLR2 showed a significantly 
higher expression in the small intestine in mice with conventional microbiome 





found that the germ-free condition can induce the expression of Tlr2-specific genes 
such as cebpb and fosl1a, (Yang, Koch and Spaink, unpublished data). This induction of 
the transcription factors that were already indicated to be downstream of TLR2 
signaling in chapter 2, was also shown to be dependent on Myd88 and Tlr2. Further 
studies into the function of TLR2 in the response of the gut to the microbiome are 
currently undertaken in our laboratory. 
Tlr2 is widely expressed in various tissue and cells (15, 16) including immune cells 
(17), intestinal epithelial cells (18) and skin (19, 20) in teleost. We also performed 
studies with external stimulation with TLR2 ligand-Pam3CSK4 in zebrafish larvae that 
have not been included in this thesis. In these studies we used Q-PCR to analyze the 
expression of various genes that were predicted to be downstream of TLR2 signaling 
and found a dose-dependent inflammatory response (unpublished data). These results 
indicate that Tlr2 also functions in zebrafish skin. 
To study the downstream effects of Tlr signaling in zebrafish we analyzed zebrafish 
TNF receptor associated factor 6 (Traf6) and inhibitor of kappa B kinase beta (Ikkβ, 
Ikk2) mutants in Chapter 4. These mutants are the result of a point mutation that 
leads to stop codons in the beginning of the reading frames of these genes. Both 
mutants did not show any visible abnormal organ phenotype during embryonic or later 
developmental stages, and the adults were also capable of breeding. These results are 
unexpected, since total deficiency of Traf6 or Ikk2 in rodents is lethal.  
In the case of the traf6 mutant, there is no significant difference with the wildtype in 
leukocyte development and mycobacterial infection phenotypes. We hypothesized that 
the traf6 mutation does not result in a null mutant at the protein level. There could be 
an alternative start codon close to the mutation point that leads to reinitiation of 
translation of Traf6. We did find that there is another ATG, close to the predicted start 
codon, that if used as an alternative start codon would lead to a slightly shorter Traf6 
protein. Although several of the amino acids in the resulting deletion are conserved in 
the mammalian counterparts, one of the predicted essential domains in the N-terminal 
moiety, the RING domain, would not be affected and therefore it is conceivable that a 
resulting protein as a result of translational reinitiation might be at least partially or 
perhaps fully functional. However, we do not know how likely this hypothesis is, since 
to our knowledge the capacity of the zebrafish translation machinery to restart 
translation shortly after a stop codon that pertubs a natural reading frame is currently 
unknown. Another explanation is that the traf6 mutation effect has been rescued by 
another mutation in the genome that resulted from the saturating ENU methodology 
used for mutagenesis that was not bred out of the original founder line. An indication 
for this is that we only obtained one single homozygote after the first generation 
incross. Such a suppressor mutation could have led to misregulation of close paralogs 




mutation is suppressed by mutation of unrelated proteins that function in the TLR or 
TNF signalling pathways. This would be similar to the published suppression of 
mutants of Ikk2 by mutations in Tnfr1 (21). Therefore, it is needed to construct new 
mutants of Traf6 for further comparative studies. 
We found that Ikk2 mutant larvae show a significant decrease in body size, 
leukocyte numbers and expression of marker genes for macrophages and neutrophils. 
Furthermore, the mutant also showed an increased bacterial proliferation after M. 
marinum infection. Unexpectedly, we found that in the ikk2 mutant a significantly 
higher expression of il1b was induced by flagellin injection than in the control. This 
result might be attributed to the overexpression of ikk1 in the ikk2 mutant, which 
perhaps plays a compensatory role in il1b expression. IKK1 is necessary for activation of 
the non-canonical or alternative NF-κB pathway (22). Functioning as one of the 
catalytic subunits of the IKK complex, IKK1 shows a similar structure as IKK2 (23). This 
hypothesis could be further studied by the construction of double mutants of Ikk1 and 
Ikk2 in zebrafish. 
IKK2 has been shown to play a role in insulin signaling in mammals. For instance, 
mice with Ikk2 inhibition or deficiency reverse obesity- and diet-induced insulin 
resistance (24-26). In our study, we found that the insulin resistance induced by 
hyperinsulinemia in zebrafish was modulated in the Ikk2 mutant. The mechanism 
underlying these results might be related to the degradation of ribosomal protein S6 
kinase (S6K) in the absence of IKK2 activation (27). S6K shows a negative feedback 
regulation to insulin receptor substrate 1 (IRS1) under conditions of nutrient satiation 
(28) (Fig. 1). The activation of IKK2 inhibits the degradation of S6K after 
phosphorylated by c-Jun N-terminal kinase 1 (JNK1), allowing S6K activation by mTOR 
(mechanistic target of rapamycin), which stabilizes S6K (27) (Fig. 1). Furthermore, 
IKK2 can also phosphorylate IRS1 on serine residues, leading to attenuation of tyrosine 
kinase- mediated signaling from the insulin receptor, interference of normal insulin 
action, and subsequent insulin resistance (32). Similar to IKK2, activation of JNK1 also 
results in inhibitory serine phosphorylation of IRS-1 (31). Both IKK2 and JNK1 can be 
activated by the initiation of TLR signaling, which indicates that TLR activation is 
indirectly involved in insulin resistance. Additionally, proinflammatory cytokines, such 
as TNFα, play important roles in diet- or obesity-induced insulin resistance. In 
adipocytes of mammals, free fatty acids can induce TNFα production through TLR2 
signals, combined with increased TLR2 expression, which is associated with the 
development of high fat-induced insulin resistance (33). Free fatty acids also can 
activate myeloid proinflammatory cells via TLR2 and TLR4 and JNK signaling pathways, 
thereby promoting inflammation and subsequent cellular insulin resistance (34). 
Moreover, a loss of function mutation in TLR4 in mice prevents diet-induced obesity 







FIGURE 1: The interaction between TLR and insulin signaling in mammals. IKK2 and JNK1 modulate 
insulin signaling through targeting IRS1 and S6K. S6K negatively regulates IRS1 through 
phosphorylating Serine 307 and Serine 636/ Serine 639 sites on IRS1, which are involved in obesity- 
and/or diet-induced insulin resistance (29, 30). S6K activation requires phosphorylation at two stages. 
The first phosphorylation is mediated by JNK1 and the second phosphorylation is mediated by mTOR. 
Figure adapted from Patel et al. (31) and Zhang et al. (27). 
 
However, the conclusion that IKK2 deficiency reverses insulin resistance has also 
been challenged by the study of Rohl et al (36), who showed that Ikk2 expression in 
mice skeletal muscle is not essential for obesity-induced insulin resistance in mice (36). 
Considering these conflicting results, additional studies of the function of IKK2 in 
insulin resistance are necessary. We expect that our zebrafish Ikk2 mutant will be of 
great use for such studies. 
In conclusion, TLR signaling plays pivotal roles in regulating host innate immunity 




of different TLR signaling pathways through RNA deep sequencing, and showed 
common and specific downstream signaling that have not been previously described 
(Chapter 2). We show the roles of Tlr2 signaling in host defense against infection at 
the transcriptome- and cellular- level by studying M. marinum infection in a tlr2 
mutant (Chapter 3). Our tlr2 mutant shows a high suitability for studies of other 
microbial infection agents, the responses of the host to the gut microbiome and 
metabolic diseases such as diabetes type II. In the study of Chapter 4, the ikk2 mutant 
shows its functions not only in innate immune protection against infection but also in 
modulation metabolism such as insulin resistance induced by hyperinsulinemia. These 
studies provide new possibilities to further study the connection of innate immunity 
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In dit proefschrift beschrijf ik mijn studies naar de zebravisorthologen van de 
menselijke TLR5- en TLR2-receptorgenen. Dit zijn genen van het aangeboren 
immuunsysteem die verantwoordelijk zijn voor, respectievelijk, de herkenning van 
bacterieel flagelline en een breed spectrum aan bacteriële celwandcomponenten. Een 
belangrijk aandachtspunt van dit proefschrift is het verschil in het netwerk van genen 
dat door TLR5- en TLR2-signaaltransductie op transcriptioneel niveau wordt 
aangestuurd. Bovendien heb ik onderzoek gedaan naar andere genen die een centrale 
rol spelen in de TLR-signaaltransductie, waaronder TRAF6 en IKK2. Om de biologische 
functies van deze immuungenen te bestuderen heb ik onderzocht hoe zebravislarven 
reageren op infectie met de vispathogeen Mycobacterium marinum, een naaste verwant 
van Mycobacterium tuberculosis, de bacterie die bij de mens tuberculose veroorzaakt.   
Om inzicht te verkrijgen in de systeembiologie van genregulatie door TLR-receptoren 
heb ik gebruik gemaakt van nieuwe mogelijkheden voor genoombrede analyse van 
genexpressie, genaamd transcriptoomanalyse, waarbij alle geproduceerde RNA-
moleculen worden gekwantificeerd met behulp van sequentiebepaling. Ook heb ik 
verschillende genetische methoden gebruikt om de activiteiten van genen te 
verminderen (knockdown) of uit te schakelen (mutatie) om daarmee de functies van 
genen in de TLR-signaaltransductie verder te onderzoeken.  
In hoofdstuk 2, wordt aangetoond dat signaaltransductie door Tlr2 in zebravislarven 
op dezelfde manier functioneert als in zoogdiercellen. Dit is getest door analyse van de 
regulatie van genexpressie van bekende immuungenen na stimulatie van 
zebravisembryo’s met lipopeptiden. Voor deze studie hebben we gebruik gemaakt van 
een stof genaamd Pam3CSK4. Dit is een synthetisch lipopeptide dat het geacyleerde 
aminozuuruiteinde van bacteriële lipoproteïnen nabootst en dat in experimenten met 
zoogdiercellen vaak gebruikt wordt om TLR2 te activeren. De transcriptoomprofielen 
die het gevolg zijn van de signaaltransductie door TLR2 en TLR5 na stimulatie door 
Pam3CSK4 en flagelline zijn bepaald met behulp van diepgaande sequentieanalyse van 
RNA-moleculen. De resultaten laten zien dat er een relatief kleine overlap is tussen de 
reacties op transcriptoomniveau na stimulatie door Pam3CSK4 en flagelline. De 
overlap omvat een groep van bekende immuunsysteemfactoren waarvan voorheen al 
aangetoond was dat ze geïnduceerd worden door flagelline, zoals de genen il1b, tnfa, 
irak3, mmp9, cxcl-c1c en il8. Opvallend is dat de genen il6 en il10, die geassocieerd zijn 
met een anti-inflammatoire reactie, veel sterker geïnduceerd worden door Pam3CSK4 
dan door flagelline. Een relatief veel grotere groep genen vertoonde een volledig 
verschillende reactie op Pam3CSK4 of flagelline, waaronder een groep genen waarvan 
de transcriptie alleen reageert op één van de twee behandelingen.  De groep genen die 
specifiek alleen reageert op de stof Pam3CSK4 omvat een aantal transcriptiefactoren 
die meer dan twee keer omhoog gaan in expressie zoals cebpb, fosb, nr4a1 en egr3.  Er is 
vervolgens aangetoond dat de activering van de groepen van genen die specifiek 




uitschakelen van, respectievelijk, Tlr2 of Tlr5.  Deze studie toont daarmee aan dat 
toediening van Pam3CSK4 of flagelline aan zebravislarven specifiek de 
signaaltransductie door Tlr2 of Tlr5 kan activeren met als gevolg een aantal reacties 
waarvan sommige algemeen zijn voor beide behandelingen en andere uitsluitend met 
één van de behandelingen optreden.  
Om de functie van Tlr2 in de afweer van de gastheer tegen infectie door M. marinum 
verder te bestuderen hebben we, zoals beschreven in hoofdstuk 3, een infectiestudie 
uitgevoerd met zebravislarven die gemuteerd zijn in dit gen. De Tlr2-specifieke genen 
die in hoofdstuk 2 waren geïdentificeerd vertonen een significante verhoging van de 
transcriptie na infectie met M. marinum in het wildtype maar echter niet, of minder 
sterk, in de Tlr2-mutant. Bovendien bevatten ongeïnfecteerde Tlr2-mutanten een 
verminderd aantal macrofagen, wat mogelijk veroorzaakt wordt door een afwijking in 
de productie en differentiatie van hematopoietische stamcellen.  Na infectie met M. 
marinum vertoont de mutant een verhoogde proliferatie van bacteriën en een 
gereduceerd aantal granulomen. De resultaten wijzen er ook op dat macrofagen in de 
Tlr2-mutant een hogere migratiesnelheid hebben, aangezien de maximale afstand van 
migratie van geïnfecteerde macrofagen vanaf een infectiebron groter was dan in de 
heterozygote controle. Dit zou mogelijk verklaard kunnen worden doordat Tlr2-
deficiënte macrofagen minder actief zijn in fagocytose. Vervolgens zijn de 
transcriptoomreacties op infectie bepaald in de Tlr2-mutant en de heterozygote 
controle met behulp van RNA-sequentieanalyse. De resultaten tonen aan dat de 
mutatie van Tlr2 als gevolg heeft dat er veel minder verandering in de 
transcriptieniveaus van immuungenen plaatsvindt na infectie met M. marinum. 
Daarnaast zijn andere genen betrokken bij diverse processen, zoals oxidatie-reductie, 
DNA-herstel, transcriptionele regulatie en apoptose, afhankelijk van Tlr2 voor hun  
transcriptionele reactie op infectie. De interacties tussen de genen waarvan de 
regulatie afhankelijk is van Tlr2 zijn onderzocht met een methode voor de analyse van 
genetische netwerken. Een voorbeeld van een resultaat dat met deze netwerkanalyse is 
gevonden is dat de signaaltransductiemechanismen die door vitamine D worden 
gereguleerd normaalgesproken worden geactiveerd als gevolg van infectie, maar in de 
Tlr2-mutant juist worden uitgezet. Dit is interessant omdat al eerder was aangetoond 
dat vitamine D een belangrijke regulerende factor is tijdens de ontwikkeling van 
tuberculose en ook in studies met celculturen in verband is gebracht met de functie 
van Tlr2. Samenvattend kan uit deze resultaten geconcludeerd worden dat Tlr2 een rol 
speelt als beschermende factor tegen infectie met mycobacteriën.  
Om de functies te bestuderen van factoren die een rol spelen in de signaaltransductie 
door de Tlr-receptoren is er in hoofdstuk 4 een analyse uitgevoerd van 
zebravisstammen met mutaties in de genen traf6 en ikk2. Deze mutaties betreffen 
puntmutaties die leiden tot een stopcodon in het begin van de eiwitleesramen van 
deze genen. Beide mutanten vertoonden geen zichtbare orgaanafwijkingen tijdens de 
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embryonale en latere ontwikkelingsstadia en de volwassen vissen waren ook in staat 
zich normaal voort te planten. Deze resultaten waren onverwacht omdat 
knaagdiermutanten waarin dezelfde genen  zijn uitgeschakeld niet levensvatbaar zijn.  
In het geval van de Traf6-mutant bleek er geen significant verschil met het wildtype 
wat betreft ontwikkeling van leukocyten en het verloop van het proces van infectie met 
mycobacteriën.  Dit leidde tot de hypothese dat de bestudeerde mutatie in het traf6-
gen niet resulteert in een uitschakeling van de functie op eiwitniveau. Dit is mogelijk 
het geval doordat er een alternatief startcodon dichtbij de mutatiepositie aanwezig is 
dat gebruikt kan worden om de eiwittranslatie opnieuw op te starten. Hoewel het 
ontbrekende gedeelte van dit hypothetische resulterende eiwit wel aanwezig is in de 
homologen van Traf6 in zoogdieren, is het overblijvende gedeelte mogelijk nog 
functioneel omdat dit het zogenoemde RING-domein bevat, dat bekend staat als een 
essentieel domein in het N-terminale gedeelte van het Traf6-eiwit. Het is echter niet 
bekend of de translatiemechanismen in de zebravis in staat zijn opnieuw op te starten 
na een stopcodon. Een andere mogelijke verklaring voor het gebrek aan fenotype van 
de Traf6-mutant is dat de mutatie gecompenseerd wordt door een andere mutatie in 
het genoom die het resultaat is van de gebruikte mutagenesemethode. Een aanwijzing 
voor deze verklaring is dat we slechts één homozygote mutant verkregen na het 
inkruisen van de eerste generatie heterozygote stamouders. Deze andere mutatie kan 
geleid hebben tot een verkeerde regulatie van naaste verwanten van het Traf6-eiwit die 
mogelijk de functie van Traf6 kunnen overnemen. Het is daarom noodzakelijk om 
nieuwe mutanten in het traf6-gen te construeren om deze mogelijkheden verder te 
onderzoeken. 
Larven van de Ikk2-mutant vertoonden een significante afname in lichaamsgrootte, 
aantallen leukocyten en transcriptionele expressie van merkergenen van macrofagen 
en neutrofielen. Verder vertoonde deze mutant een toegenomen bacteriële proliferatie 
na infectie met M. marinum vergeleken met het wildtype. Een onverwachte 
waarneming was dat het bekende immuungen il1b een hogere expressie had na injectie 
van flagelline dan in de controle. Dit resultaat kan mogelijk verklaard worden doordat 
de expressie van het gen dat codeert voor Ikk1 verhoogd is in de Ikk2-mutant en dat dit 
gen een compenserende rol speelt om het il1b-gen aan te zetten. Deze hypothese kan 
verder getest worden door de constructie van dubbelmutanten van Ikk1 en Ikk2. Er is 
in voorgaand onderzoek aangetoond dat Ikk2 een rol speelt in insuline-
signaaltransductie in zoogdieren. In overeenstemming hiermee hebben wij gevonden 
dat de resistentie tegen insuline die wordt geïnduceerd door een overmaat aan insuline 
gemoduleerd is in de Ikk2-mutant van de zebravis.  
De hoofdconclusie die uit deze studies kan worden getrokken is dat TLR-
signaaltransductie een essentiële rol speelt in de immuniteit en het bewaren van een 




activering van verschillende TLR-receptoren zijn in dit proefschrift op systeemniveau 
beschreven. Hiermee is aangetoond dat er naast algemene effecten ook specifieke 
effecten zijn die door de TLR2- en Tlr5-receptoren worden geactiveerd en die nog niet 
eerder bekend waren (Hoofdstuk 2).  Door gebruik te maken van een Tlr2-mutant is 
inzicht op het niveau van transcriptie en cellulaire reacties vekregen in de rol van Tlr2 
bij de afweer van zebravislarven tegen infectie met M. marinum (Hoofdstuk 3).  Deze 
Tlr2-mutant is erg geschikt voor toekomstige studies naar andere microbiële infecties, 
naar de reactie van de gastheer op de microbiële darmflora en voor onderzoek naar 
metabole afwijkingen zoals diabetes type II waarbij het immuunsysteem een belangrijk 
rol speelt. In de studie beschreven in hoofdstuk 4 is gebleken dat de Ikk2-mutant 
naast een functie in de aangeboren afweer tegen mycobacteriële infectie ook een rol 
speelt in de regulatie van het metabolisme, zoals aangetoond door het effect van de 
mutatie op insulineresistentie die wordt geïnduceerd door een overmaat aan insuline. 
Zoals bediscussieerd in hoofdstuk 5 biedt het werk in dit proefschrift daarom nieuwe 
mogelijkheden om de koppeling tussen het aangeboren immuunsysteem en de 
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